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Abstract
Events characterized by ischemia/reperfusion (I/R), such as stroke and cardiac 
arrest, are among the most frequent causes of debilitating neurological injury and death 
worldwide. During ischemia, the brain experiences oxygen and nutrition deprivation due 
to lack of blood flow, and tissue damage ensues. Arctic ground squirrel (AGS; Urocitellus 
parryii), a hibernating species has the innate ability to survive profound decreases in 
blood flow (ischemia) during torpor and return of blood flow (reperfusion) during 
intermittent euthermic periods without any neurological deficit. However, the mechanisms 
by which AGS tolerate the extreme fluctuations in blood flow remain unclear.
The main focus of this thesis is to investigate the modulation of I/R injury in 
mammalian hibernators and non-hibernators. The first study validates the microperfusion 
approach for studying in vitro I/R injury (oxygen glucose deprivation, OGD) modeled in 
acute hippocampal slices and investigates the complex interactions of glutamate- 
mediated excitotoxicity with acidosis-mediated acidotoxicity to understand the role of 
acid-sensing ion channels (ASIC1a) and pH in mediating cellular injury during OGD. 
Using an ischemic tolerant animal model, AGS, the second and third studies explore if 
hibernation season or state influences tolerance to I/R injury and tests hypotheses 
regarding mechanisms involving nitric oxide and superoxide radicals in mediating cellular 
damage during cerebral I/R.
Together, this dissertation demonstrates that when OGD is combined with acidosis 
as occurs in vivo, acidotoxicity mediated via ASIC1a occurs but low pH abolishes NMDAR 
mediated excitotoxicity. This dissertation also presents evidence that AGS tolerate OGD 
injury independent of hibernation season and state. At the tissue level, when tissue
iii
temperature is normalized to 36°C despite ATP depletion, ionic derangement, tissue 
acidosis, and excitatory neurotransmitter efflux, AGS hippocampus resists OGD injury. 
Finally, the dissertation shows that AGS resist brain injury caused by ONOO- generated 
from NO or O2~ during OGD while rat brain tissue succumbs to this mechanism of injury.
iv
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CHAPTER 1: General introduction to ischemia/reperfusion injury and the mechanism of
neuroprotection in mammalian hibernators
1.1 Overview
Neurological diseases of diverse etiologies such as stroke, traumatic brain injury 
and other neuropathies such as Alzheimer’s disease have significant effects on the quality 
of life of patients. The limited self-repairing capacity of the brain is considered to be the 
origin of the irreversible and progressive nature of many neurological diseases. 
Therefore, neuroprotection is an important goal shared by many clinical neurologists and 
neuroscientists. Although pre-clinical findings to combat these etiologies have been 
promising, not much success has been achieved and requires the need for a novel 
approach. In the present project, tolerance to ischemia/reperfusion (I/R) injury is 
investigated in Arctic ground squirrels (AGS; Urocitellus parryii).
Here, in Chapter 1, the cascade of events associated with I/R injury and the 
mechanism of neuroprotection in mammalian hibernators is reviewed. Also, I discuss the 
rationale for the use of acute hippocampal slices as a model to investigate 
neuroprotection and the microperfusion approach for studying neuroprotective 
mechanism in mammalian hibernators. Finally, the scope and aims of the project are 
described. Chapter 2 addressed two research objectives. First, oxygen-glucose 
deprivation (OGD) injury via the microperfusion approach was induced in acute 
hippocampal slices from rats to validate if the in vitro microperfusion approach mimics I/R 
injury that occurs under in vivo conditions. Results demonstrate that OGD injury via the 
microperfusion approach causes disruption in energy homeostasis and excitatory 
neurotransmitter efflux similar to in vivo I/R injury. Second, Chapter 2 also tests the
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hypothesis that low pH during OGD blocks NMDA-mediated excitotoxicity but produces 
acidotoxicity via ASIC1a and helps to resolves the controversy regarding the relative 
importance of acidotoxicity and NMDAR mediated excitotoxicity in I/R injury. Using the 
novel microperfusion technique, this study separates the effect of pH and oxygen glucose 
deprivation and for the first time provides time-resolved observations demonstrating that 
acidosis abolishes OGD-induced excitotoxicity, but induces acidotoxicity via ASIC1a 
channels. Chapter 3 challenges the dogma that tolerance to cerebral I/R is conveyed by 
the hibernation state or season by demonstrating that AGS lack seasonal dependence of 
ischemic tolerance. This study shows that at the tissue level, hibernation season or the 
torpid state has no influence on oxygen-glucose deprivation (OGD)-induced cell death in 
Arctic ground squirrel (AGS). Moreover, AGS are highly tolerant to OGD compared to 
ischemic susceptible Sprague-Dawley rat despite the loss of ATP, excitatory amino acid 
release, and acidosis and persists during conditions that mimic acidosis and ischemic 
shift characteristics of cerebral I/R injury in vivo. In Chapter4, I demonstrate that ONOO- 
injures rat hippocampal slices during modeled ischemia and requires both nitric oxide 
(NO) and superoxide (O2~); neither species is injurious alone. Rats are prone to this 
mechanism of injury whereas in AGS this mechanism of injury is absent which explains 
the profound tolerance AGS have for cerebral I/R. Taken together the findings from this 
project indicate that elucidation of the neuroprotective mechanisms in mammalian 
hibernators is promising in the quest for therapeutics for disorders characterized by I/R 
injury.
2
1.2 Study of protective mechanisms pertinent to stroke is well warranted
According to the American Heart Association, stroke is the fifth leading cause of 
death worldwide and has devastating clinical outcomes. Each year, over 800,000 
Americans suffer a stroke, causing significant adult disability, with an estimated annual 
expenditure of $ 36.5 billion. Very few treatment options are available (Go et al. 2014). 
A stroke occurs when the blood to the brain is interrupted or reduced. This causes oxygen 
and glucose deprivation leading to brain cell death. A stroke may be caused due to 
ischemia (by a blocked artery) or hemorrhagic stroke (leaking or bursting of a blood 
vessel). Some individuals may experience only a temporary disruption of blood flow to 
their brain (transient ischemic attack, or TIA). Ischemic stroke is the most common 
accounting for 87% of total strokes. Other strokes are intracerebral hemorrhage (9%) and 
subarachnoid hemorrhage (4%). Ischemic stroke is caused most often by emboli to the 
middle cerebral artery (MCA) (Soler & Ruiz 2010).
Over the past few decades, our understanding of the pathophysiology of stroke 
has increased, but greater understanding is required to advance the field of stroke 
recovery. Tissue plasminogen activator (tPA) is the only drug currently available for 
ischemic stroke. However, tPA is advised only if administered to patients within 4.5 h after 
the onset of the stroke, thus benefits only 4% of patients (Del Zoppo et al. 2009). (Davis 
& Donnan 2009)
1.3 Pathogenesis of ischemia-reperfusion injury
Cerebral ischemia causes significant failures in cerebral blood flow. Circulatory 
failure due to cardiac arrest leads to global cerebral ischemia, while occlusion of a major 
brain artery triggers focal ischemia. Continued circulatory deficits induce irreversible
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changes in the brain tissue perpetrating neuronal damage. I/R injury initiates a cascade 
of events and ensues cell death through a number of mechanisms including both 
necrosis, a hallmark of cellular swelling, and apoptosis involving complex signaling 
mechanisms that leads to cellular death (Hotchkiss et al. 2009)
1.3.1 Loss of ion homeostasis and energy status
The most upstream consequences of cerebral ischemia are a disruption in energy 
and ion homeostasis. The central nervous system (CNS) is extremely susceptible even 
to small changes in metabolism or availability of substrate. Due to reduced cerebral blood 
flow during ischemia, ATP consumption continues despite insufficient ATP synthesis 
(Santos et al. 1996). Depletion of ATP affects the normal functioning of the ATP- 
dependent ion pump, Na+-K+-ATPase that is responsible for maintaining ion homeostasis. 
The Na-K ATPase pump is an electrogenic transmembrane enzyme located in the plasma 
membrane that catalyzes the active transport of Na+ ions out and K+ ions into the cells 
(Skou 1988). Na+-K+-ATPase plays a critical role in maintaining resting membrane 
potential of neurons, cell volume and transmembrane fluxes of Ca2+ and extracellular 
levels of excitatory neurotransmitters (Albers & Siegel 2012). Failure of the Na+-K+- 
ATPase pump depletes intracellular K+, accumulation of intracellular free Ca2+ by 
activation of voltage-gated Ca2+ channels, and reversal of the Na+ / Ca2+exchanger 
(DiPolo & Beauge 1991), and an increase in extracellular levels of glutamate.
1.3.2 Glutamate-mediated excitotoxicity
Excessive release of an excitatory neurotransmitter such as glutamate is thought 
to play a key role in the excitotoxic neuronal death (Benveniste et al. 1984). Under 
ischemic conditions, an excessive amount of glutamate is released reaching to near-
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millimolar concentrations in the extracellular space (Featherstone 2010). This causes 
overstimulation of N-methyl-d-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4- 
isoxazolepropionic acid (AMPA), and kainate-type glutamate receptors. The heteromeric 
NMDA receptor-gated ion channels are highly permeable to Ca2+ as well as Na+ and K+. 
This results in a high influx of intracellular Ca2+ overload. Previous studies demonstrated 
that exposure to NMDA for 3-5 min is sufficient to trigger neuronal death (Lee et al. 2000) 
whereas selective blockade of NMDA receptor ameliorate cell death in both in-vitro and 
in vivo models (Albers et al. 1989, Choi 1992, Choi 1988) indicating that glutamate-gated 
NMDAR plays an important role in causing excitotoxicity associated with I/R injury. 
Although effective in reducing ischemic damage of brain tissue in animal models, 
glutamate receptor antagonists have not been effective in clinical trials of stroke 
(Ikonomidou & Turski 2002). In addition to glutamate mediated excitatoxicity, drop in pH, 
an early events of I/R injury may play a role in cell death. Other targets that are activated 
due to drop in pH such as acid sensing ion channels (ASICs) has spurred new avenues 
for stroke therapy from the lesson learned from failures of glutamate receptor antagonists 
in clinical trails of stroke.
1.3.3 Low pH-mediated acidotoxicity
During ischemia, anaerobic metabolism prevails due to O2 deprivation. This results 
in accumulation of lactic acid as a by-product of glycolysis and leading to acidosis. 
Extracellular and intracellular acidosis occurs following ischemia and has been 
considered as a primary cause of cell death (Siesjo 1988). Recent studies have shown 
that increased load of proton due to acidosis (Rehncrona et al. 1981, Kalimo et al. 1981) 
activates a distinct family of ligand-gated channels, the acid-sensing ion channels
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(ASICs,ENaC/Deg superfamily) (Waldmann et al. 1997, Baron et al. 2002, Alvarez de la 
Rosa et al. 2003). ASICs are expressed throughout the central and peripheral nervous 
system (Kweon & Suh 2013). Previous studies demonstrated that activation of ASIC1a 
increased intracellular Ca2+concentration in hippocampal, cortical, and dorsal root 
ganglion (DRG) neurons (Yermolaieva et al. 2004, Xiong et al. 2004) and led to neuronal 
injury during brain ischemia accompanied by prolonged acidosis (Xiong et al. 2004, 
Pignataro et al. 2007). This points towards targeting ASIC1a as a neuroprotective target 
for brain ischemia (Yermolaieva et al. 2004, Xiong et al. 2008).
1.3.4 Calcium dysregulation
The cytoplasmic concentration of free Ca2+ of the resting neuron is extremely low 
(approximately 100nm) whereas the extracellular concentration is about 1-2 mM. The 
intraneuronal levels of Ca2+ are maintained through (a) the entry of extracellular 
concentration of ligand -operated receptor or voltage-gated ion channels, (b) the release 
of Ca2+ from endoplasmic reticulum or from the mitochondria through Na+-Ca2+ 
exchanger, (c) the extrusion of Ca2+ through Ca2+-ATPase or Na+-Ca2+ exchanger in the 
plasma membrane, (d) the binding of Ca2+ to target protein, and (e) Ca2+ sequestration 
into the endoplasmic reticulum through Ca2+-ATPase or mitochondria through uniport 
mechanism (Gill et al. 1989, Carafoli 1991, Gunter & Pfeiffer 1990). During ischemic 
insult, Ca2+ ion reaches critical levels leading to cell death (White et al. 1984). The influx 
of Ca2+ through NMDA receptors appears to underlie a major portion of Ca2+ overload. 
Other ion pumps and channels that cause high intracellular Ca2+ influx includes acid 
sensing ion channels (Xiong et al. 2004), the Na+/Ca2+ exchanger (Bano et al. 2007), TRP 
channels (Aarts & Tymianski 2005) and hemichannels (Contreras et al. 2004). Excess of
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Ca2+ ion concentrations activate proteases, lipases, phosphatases, and endonucleases. 
Their over-activation may result in the damage of cell structures and further oxidative 
stress. Ca2+ overload can trigger several downstream lethal reactions, including 
nitrosative and oxidative stress, lipid peroxidation, and mitochondrial dysfunction 
culminating in cell death (Orrenius et al. 2003). The rapid rise in intracellular Ca2+ 
following ischemia can also lead to both apoptotic and necrotic cell death (Simon et al. 
1984, Xiong et al. 2004). Therefore, targeting Ca2+ influx-efflux mechanisms may be a 
valuable approach to counteract Ca2+ dysregulation associated with I/R injury.
1.3.5 Free radical production during ischemia and reperfusion
Oxidative and nitrosative stress are also potent mediators of ischemic injury. Under 
the normal physiological condition, the redox environment of cells modulates signal 
transduction cascades that balance between pro-death and pro-survival pathways (Crack 
& Taylor 2005). However, during I/R injury, ROS and RNS, such as hydroxyl radical, 
superoxide, and peroxynitrite, are highly reactive and damaging to multiple cellular 
components, leading to cell death. In the brain, NO is formed by the NO synthase (NOS) 
isoforms, a family of enzymes (Guix et al. 2005, Calabrese et al. 2007). Under 
physiological conditions, NO contributes to autoregulation of cerebral blood flow (CBF) 
(Toda et al. 2009). However, during ischemia, cerebral NO rapidly increases to 2-4 ^M, 
producing damaging levels of NO (Murphy 1999, Kader et al. 1993). Concomitantly, a 
burst of free radicals such as O2~ (Cuzzocrea et al. 2001, El Kossi & Zakhary 2000, Tang 
et al. 2012, Suh et al. 2008) is produced after the ischemic event. This scenario is 
deleterious because O2 - anion has a high affinity for NO, higher than for the superoxide 
dismutase (Huie & Padmaja 1993, Cudd & Fridovich 1982). NO and O2 - react with each
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other in an equimolar stoichiometric ratio forming a potent oxidant, ONOO- further 
contributing to injury (Beckman et al. 1990, Reiter et al. 2000, Zielonka et al. 2010).
Accumulating evidence demonstrates that excitotoxicity, acidotoxicity and 
oxidative stress contribute to hypoxic-ischemic cell death through mutually independent 
pathways. To date, glutamate antagonists, antioxidants, or ASICs blocker have been 
examined to treat hypoxic-ischemic brain injury. However, the therapeutic effectiveness 
of neuroprotective drugs against excitotoxicity, acidotoxicity or oxidative stress are not 
designed to counter deleterious effects on the other cell death pathways that also 
participate in the process of hypoxic-ischemic neuronal death. A better understanding of 
how these pathways impact I/R injury and how they interact during I/R injury is highly 
warranted for maximal neuroprotection against hypoxic-ischemic injury. Investigations of 
mammalian hibernators may yield insight into mechanisms that protect against I/R. These 
mechanisms may then translate to non-hibernators for the development of effective stroke 
therapies.
1.4 Hibernation and neuroprotection
1.4.1 Hibernation physiology
Mammalian hibernators display an amazing phenotypic switch that involves profound 
changes in physiology, morphology, and behavior during unfavorable environmental 
conditions. This unique phenotype is thought to have evolved in response to food 
shortage and utilize a host of protective mechanisms to survive harsh environmental 
conditions in which hibernating species live (Wang et al. 1988). Various mammalian 
species, including one species of primate (Dausmann et al. 2004), rodents, bats, 
carnivores, and marsupials (Carey et al. 2003) hibernate with similar characteristics.
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Arctic ground squirrel (AGS), a species native to the northern slope of the Brooks Range 
and other regions in Alaska, hibernate for approximately 7-8 months each year (Barnes 
1989). During hibernation, AGS and other species of ground squirrel enter a highly 
regulated and reversible state of prolonged torpor. The period of torpor is characterized 
by a profound decrease in respiratory rate, heart rate, blood flow, cerebral perfusion, and 
body temperature (Tb). During torpor, body temperature (Tb) falls to within a few degrees 
of the ambient temperature (Carey et al. 2003). During torpor, body temperature (Tb) 
typically ranges from 2 to 10°C for most temperate-zone hibernators; however, in AGS, 
body temperature can drop to as low as -2.9°C (Barnes 1989) and metabolism can be 
reduced to 1-2% of resting metabolic rate. Torpor bouts are interrupted by arousal 
periods in which the AGS enters the state of interbout euthermy (Barnes 1989). During 
an arousal in AGS, physiological changes that took place during torpor return to 
normothermic values for approximately 24h periods (Daan et al. 1991). Species that 
hibernate differ in hypothermic basal temperature while in torpor or in the duration of 
torpor bouts, but when Tb falls below 30°C all have in common the need to undergo 
periodic arousals between bouts and experience prolonged torpor throughout their 
hibernation season (Carey et al. 2003, Dausmann et al. 2004).
1.4.2 Hibernating animals as a model to study neuroprotective mechanisms
Hibernating species are a natural model of tolerance to insults, such as ischemia, 
that would be injurious to non-hibernating species. Tolerance to hypoxia in hibernating 
species was first documented in the early 1800’s (Biorck et al. 1956). Although 
hibernating animals experience prolonged ischemic-like low levels in blood flow during 
torpor and the reperfusion-like return of blood flow during arousal, no neuronal damage
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ensues (Ma et al. 2005, Frerichs et al. 1994). As early as the 1960’s, the mechanisms of 
hypoxia tolerance in hibernating species were proposed to be attributable to factors other 
than cold temperature (Bullard & Funkhouser 1962) that includes hypo-metabolism, 
differential modulation of NMDAR, immunosuppression, anticoagulant properties of the 
blood and antioxidant defenses (Zhou et al. 2001, Drew et al. 2001).
Tolerance to traumatic brain injury has been demonstrated in hibernating AGS in 
vivo (Zhou et al. 2001). Previous in vitro studies in Thirteen-lined ground squirrel 
explained that hibernation season (Kurtz et al. 2006, Lindell et al. 2005) or lowering 
temperature (Frerichs & Hallenbeck 1998) in brain slices from active animals contributes 
towards tolerance to I/R injury. Later, in vivo studies demonstrated that tolerance is not 
just attributed to hibernation season or hypothermia, since, AGS and other species of 
ground squirrel tolerate hypoxia (D'Alecy et al. 1990) and ischemic-like conditions even 
when they are not hibernating (Dave et al. 2009, Dave et al. 2006). This indicates that 
resistance to I/R injury in hibernators is not just attributed to hibernating season or 
hypothermia but could also be due to tissue and circulating factors that persist in summer 
active hibernators. Investigation of the mechanisms in hibernating species that provide 
this protection from insults is a promising approach for the quest for effective therapeutics 
for stroke.
1.4.3 Other anoxia and hypoxia-tolerant model systems
1.4.3.1 Naked mole rat
Naked mole rat (Heterocephalus glaber) is a cold-blooded (Buffenstein & Yahav 
1991) fossorial animal that experiences chronic environmental hypoxia (low oxygen 
environment) without any damage (Larson & Park 2009). Naked mole rats have
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specialized circulatory (High-O2-affinity hemoglobin) (Johansen et al. 1976) and 
metabolic functions (low resting metabolism) (Buffenstein & Yahav 1991) that helps them 
to cope with chronic hypoxic conditions. In addition to chronic environmental hypoxia, 
naked mole-rats also experience acute hypoxia during certain behaviors such as foraging 
and tunnel excavation. Previous studies demonstrated that hippocampal slices from adult 
naked mole-rats manifest extreme tolerance to hypoxia in at least three ways, compared 
to other mammalian species: maintainance of synaptic transmission under more hypoxic 
conditions; anoxic depolarization time is delayed after total oxygen deprivation, and slices 
recover electrophysiological responsiveness after much longer periods of anoxia (Larson 
& Park 2009).
Arrested brain development has been suggested as a mechanism for naked mole 
rat adaptation of tolerance to hypoxic insult. This predominant mechanism was proposed 
based on high expression level of NMDA receptor GluN2D subunit in adult naked mole- 
rat (Peterson et al. 2012). GluN2D has previously been shown to play a role in hypoxia 
tolerance in neonatal rat brain (Bickler et al. 2003). Therefore, high expression of GluN2D 
subunit in naked mole-rat brain suggests retention of a neonatal feature into adulthood. 
Recent studies have shown that naked mole rat survive anoxia by switching to anaerobic 
metabolism fueled by fructose (Park et al. 2017).
1.4.3.2 Turtle
Several species of turtle tolerate hypoxia and have been studied in great detail. 
Fresh water turtle (Trachemys scripta) is one of the most robust hypoxia-tolerant 
vertebrates that can withstand a complete anoxic state for days at room temperature to 
weeks during winter at colder temperatures (Jackson & Ultsch 2010). Another species,
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Western painted turtle (Chrysemys picta bellii) can survive anoxia for 5 months at 1-3°C 
during winter (Bickler et al. 2002).
One mechanism of this profound tolerance to anoxia in turtle is accomplished by 
entering into a state of deep reversible hypo-metabolism. The state of hypo-metabolism, 
a type of hibernation that like mammalian hibernation causes less demand for ATP (70­
80%), helps the turtles to survive on the ATP generated through anaerobic metabolism 
(Hochachka & Lutz 2001). Hypo-metabolism leads to suppression of energy demanding 
processes that includes a decrease in excitatory neurotransmitter release (Milton & Lutz 
1998, Milton et al. 2002, Thompson et al. 2007), increased neural inhibition (Nilsson & 
Lutz 1991) channel arrest (reduced ion permeability) and the suppression of action 
potentials (spike arrest) (Fernandes et al. 1997).
Neurotransmitters such as y-aminobutyric acid (GABA) and adenosine also 
modulate anoxia tolerance in turtles by decreasing ionic current gated by glutamatergic 
receptors (Pamenter et al. 2012). Adenosine has also shown to affect channel arrest 
(Pek & Lutz 1997, Perez-Pinzon et al. 1993), dopamine release (Milton & Lutz 2005, 
Milton et al. 2002), NMDAR currents (Buck & Bickler 1998) and cerebral blood flow 
(Hylland et al. 1994) providing further tolerance to anoxia in turtle. In addition, NMDA 
receptor activity is reduced by 50-60% in the first few minutes of anoxia by 
dephosphorylating the receptor, which prevents excess calcium influx that can lead to 
cellular injury. The suppression of NMDA receptor activity is mediated by phosphatase 1 
or 2A, adenosine (Bickler et al. 2002, Buck & Bickler 1998) and 5-opioid receptors 
(Pamenter & Buck 2008) which are expressed in high density in the turtle brain (Xia & 
Haddad 2001). A variety of other protective mechanisms are also activated at the
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molecular level in anoxic turtle brain and other organs that includes increased levels of 
heat shock proteins (Krivoruchko & Storey 2010, Prentice et al. 2004, Stecyk et al. 2012, 
Kesaraju et al. 2009), anti-apoptotic factors, activation of MAP kinases, increased 
expression of antioxidants and modulation of the p53 pathway (Milton et al. 2008, Rider 
et al. 2009, Kesaraju et al. 2009, Nayak et al. 2011). These factors not only play a role in 
providing protection during anoxic insult but also ameliorate oxidative stress during 
reperfusion (reoxygenation).
1.4.3.3 Diving mammals
Diving mammals such as whales and seals are capable of going on long dives and 
remaining submerged for up to 2 hours (Hindell et al. 1991, Watkins et al. 1985). Diving 
mammals rely on a high concentration of hemoglobin in blood and myoglobin in muscle 
as an endogenous store of O2 as a way to cope with hypoxia (Lenfant et al. 1970, Burns 
et al. 2007). In diving mammals, during simulated diving, the arterial blood O2 tension 
drops to 7-10 mmHg (Elsner et al. 1970, Kerem & Elsner 1973) which is well below the 
critical arterial O2 tension of 25-40 mmHg, at which impairment has been reported from 
limitations in ATP (Erecinska & Silver 2001). Brains of diving mammals cope with 
repeated and extreme hypoxemia during diving. This cerebral tolerance to hypoxia 
reflects intrinsic properties of the neurons. Both adult hooded seal and mice show similar 
neuronal membrane potentials of around -60 to -70 mV. However, during ten minutes of 
hypoxia, mice neurons depolarize at around 65 mV whereas seal neurons depolarize 
around 13 mV (Folkow et al. 2008). This lower threshold for depolarization is an intrinsic 
property of the seal neurons that contributes to hypoxia tolerance.
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Deep diving-hooded seals (Cystophora cristata) also exhibit cellular differences in 
neurons that contributes to their hypoxia tolerance. Previous studies have revealed that 
neuroglobin (Ngb) facilitates O2 diffusion to maintain aerobic metabolism (Burmester & 
Hankeln 2009) and might also play a role in ROS detoxification during and after deep 
diving (Zenteno-Savin et al. 2002). Interestingly, levels of brain Ngb in deep diving seals 
does not differ from those of rats and mice (Mitz et al. 2009). However, in contrast to other 
terrestrial mammals, seals have an unusual distribution of Ngb with higher levels in 
astrocytes than in neurons (Mitz et al. 2009). Ngb in close association with mitochondria 
supports O2 supply and oxidative metabolism (Burmester & Hankeln 2009, Mitz et al. 
2009). The presence of high levels of Ngb and Cytochrome C (a component of the 
respiratory chain in the mitochondria) in astrocytes of hooded seals brain (Mitz et al. 2009) 
suggest that there are fundamental differences in the localization of aerobic and 
anaerobic metabolism between hooded seals and non-diving rodents wherein hooded 
seals might have a reversed lactate shuttle system compared with non-diving mammals 
(Mitz et al. 2009, Schneuer et al. 2012). In contrast to hooded seals, whales have a 
different Ngb distribution with higher levels in neurons than astrocytes suggesting the 
possible role of Ngb in facilitating diffusion and storage of O2 within whale neurons 
(Schneuer et al. 2012).
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1.5 An in vitro microperfusion approach to investigate neuroprotection in acute 
hippocampal slices from AGS
1.5.1 Rationale for use of acute hippocampal slices as a model to investigate 
neuroprotection
To elucidate the mechanisms associated with AGS tolerance to I/R injury, it is 
relevant to study a region of the brain that is vulnerable to I/R injury in non-hibernating 
mammals. For these studies, an in vitro approach is appropriate since the state of the 
animal cannot be maintained while manipulating body temperature in vivo. In addition, an 
in vitro approach allows for investigation of intrinsic tissue factors that correspond to 
tolerance in hibernating animals wherein factors such as cold temperature and circulating 
factors can be eliminated. In humans, the hippocampus can be affected by various insults 
such as ischemia, inflammation, hypoglycemia, or excessive metabolic demand during 
epileptic activity that may result in impairment of functional and structural neuronal 
integrity. Due to vulnerability of hippocampus to ischemia (Schmidt-Kastner & Freund 
1991), in vitro slices using the hippocampus have been extensively used for investigating 
tolerance to ischemia (Mitani et al. 1994, Djuricic et al. 1994). The major advantage of 
using hippocampal slices as a model is that it allows the separate study of different 
mechanism of ischemia-reperfusion injury unattainable in vivo. Moreover, this study used 
acute hippocampal slices rather than organotypic cultures. Organotypic cultures are used 
to model tissues in vivo and organotypic cultures of hippocampus are used commonly to 
model and study I/R injury. Because adult brain tissue does not live well in culture, 
organotypic cultures of hippocampus typically are prepared from neonatal brain tissue. 
Interpretation of organotypic cultures is therefore limited by developmental age of the
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tissue (Fukuda et al. 1995). Another advantage of acute slices of adult hippocampus is 
that the pattern of synaptic connections within the slice is minimally altered relative to the 
in vivo patterns at the time of harvest (Coltman et al. 1995).
1.5.2 Microperfusion approach: A novel method for inducing ischemia reperfusion injury 
in vitro
The novel microperfusion method developed in our laboratory (Kirschner et al. 
2009) for study of cell death in acute, adult slices overcomes the limitations of methods 
used in prior studies where high baseline cell death may have compromised 
interpretation. The microperfusion approach minimizes background cell death by 
capturing LDH release from the entire slice. This approach is an improvement over other 
methods where stains such as propidium iodide show cell death only on the surface of 
the freshly cut slice (Ross et al. 2006, Christian et al. 2008). Moreover, the microperfusion 
approach allows us to study cell death in adult AGS tissue. The ability to study adult tissue 
is an advantage since access to perinatal tissue is restricted by the seasonal breeding 
cycle of AGS. The in vitro microperfusion approach in our study might not apply to the in 
vivo scenario wherein whole animal mechanisms such as pH buffering capacity and 
limited inflammatory response contribute to tolerance to ischemia reperfusion injury 
(Bogren et al. 2014a, Bogren et al. 2014b).
Nonetheless, the microperfusion approach isolates processes occurring at the 
tissue level so that interpretation is not confounded by whole animal physiology. 
Moreover, the microperfusion approach allows for the concentration of each component 
in the perfusion fluid to be defined and manipulated and cell death quantified in a time- 
dependent manner. In this way, pH can be decreased without hypoxia and cell death
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monitored with temporal resolution relevant to onset and recovery from low pH. Such 
discrete manipulation of individual components of the extracellular milieu is not possible 
in vivo where, for example, pH decreases following anoxia. Thus, the microperfusion 
approach gives superior control over the extracellular environment that could not be 
achieved in vivo. We acknowledge that the slice preparation differs from the in vivo 
scenario (Cho et al. 2007, Saeidnia et al. 2015) and in this way, serves our objective to 
study processes at the tissue level that do not depend on cold tissue temperatures and 
confer tolerance to AGS.
1.5.3 Cell death marker: Lactate dehydrogenase
The duration and severity of the ischemic insult may also determine the extent to 
which cell damage occurs by programmed cell death mechanisms after ischemia in vivo 
(Kalogeris et al. 2012). In focal ischemia models, cells in the ischemic core predominantly 
undergo necrotic features of cell death whereas cells in the penumbra region surrounding 
the ischemic core demonstrate more apoptotic features. Necrosis is characterized by 
swelling and rupture of intracellular organelles, eventually leading to the breakdown of 
the plasma membrane (Moquin & Chan 2010, Challa & Chan 2010). One of the markers 
for quantifying necrotic cell death is to measure the release of lactate dehydrogenase 
(LDH). LDH is a soluble cytoplasmic enzyme that is present in almost all cells and is 
released into extracellular space when the plasma membrane is damaged (Burd & 
Usategui-Gomez 1973).
In this thesis, LDH release is used to interpret necrotic cell death associated with 
OGD. The LDH approach of monitoring cell death overcomes the limitations of methods
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used in prior studies where high baseline cell death challenged interpretation because of 
acute damage at the slice surface (Ross et al. 2006, Christian et al. 2008).
1.6 Specific aims
Hibernating mammals are a natural model of tolerance to ischemic and hypoxic 
insult. The purpose of this research is to explore the mechanisms that allow for ischemia 
tolerance in the AGS in an in vitro acute slice model. The aims of the dissertation were 
therefore:
1. to validate an in vitro microperfusion approach that allowed investigation of modeled 
I/R injury at the tissue level.
2. to determine the role of acidosis mediated acidotoxicity and its interaction with NMDA 
mediated excitotoxicity in ischemic/reperfusion injury
3. to assess the influence of hibernating state (i.e., hibernating or not hibernating) and 
hibernation season (i.e., winter vs. summer) on resistance to OGD in AGS brain tissue.
4. to identify if events such as depletion of ATP, acidosis, and glutamate efflux that are 
associated with anoxic depolarization are attenuated in AGS.
5. to investigate if AGS tolerate peroxynitrite (ONOO-) mediated cell death modeled in 
acute hippocampal slices.
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CHAPTER 2: Acidotoxicity via acid sensing ion channel 1a (Asic1a) mediates cell death 
during oxygen glucose deprivation and abolishes excitotoxicity1
2.1 Abstract
Ischemia-reperfusion (I/R) injury is associated with a complex and multifactorial 
cascade of events involving excitotoxicity, acidotoxicity, and ionic imbalance. While it is 
known that acidosis occurs concomitantly with glutamate-mediated excitotoxicity during 
brain ischemia, it remains elusive, how acidosis-mediated acidotoxicity interacts with 
glutamate-mediated excitotoxicity. Here, we investigated the effect of acidosis on 
glutamate-mediated excitotoxicity in acute hippocampal slices. We tested the hypothesis 
that mild acidosis protects against I/R injury via modulation of NMDAR, but produces 
injury via activation of acid sensing ion channels (ASIC1a). Using a novel microperfusion 
approach, we monitored time course of injury in acutely prepared, adult hippocampal 
slices. We varied the duration of insult to delay the return to pre-insult conditions to 
determine if injury was caused by the primary insult or by the modeled reperfusion phase. 
We also manipulated pH in presence and absence of oxygen glucose deprivation (OGD). 
The role of ASIC1a and NMDAR was deciphered by treating the slices with and without 
an ASIC or NMDAR antagonist. Our results show that injury due to OGD or low pH occurs 
during the insult rather than the modeled reperfusion phase. Injury mediated by low pH 
or low pH OGD requires ASIC1a and is ischemic cell death caused by stroke and cardiac 
arrest.
1 Published as Bhowmick S, Moore JT, Kirschner DL, Curry MC, Westbrook EG, Rasley 
BT, Drew KL. "Acidotoxicity via ASICIa Mediates Cell Death during Oxygen-Glucose 
Deprivation and Abolishes Excitotoxicity.” ACS Chem Neurosci. 2017 Mar 1. doi: 
10.1021/acschemneuro.6b00355. [Epub ahead of print]. PubMed PMID: 28117962
37
2.2 Introduction
Ischemic reperfusion (I/R) injury associated with stroke and cardiac arrest can lead 
to severe morbidity and has a mortality rate between 30-100% (Go et al. 2014). Several 
clinical trials aimed at NMDA (N-methyl-d-aspartic acid) mediated excitotoxicity have 
failed.(Lipton 2004, Hoyte et al. 2004). Acidosis exacerbates ischemic brain injury due to 
a drop in tissue pH to 6.5 -  6.0 (Rehncrona et al. 1981, Nedergaard et al. 1991). However, 
an intriguing debate has emerged regarding the influence of mild acidosis on cell damage/ 
protection during cerebral I/R injury. One line of evidence suggests that mild acidosis is 
neuroprotective (Tombaugh & Sapolsky 1990, Kaku et al. 1993) and the neuroprotection 
is due to modulation of the NMDA receptor mediated ischemic cascade (Giffard et al. 
1990, Tang et al. 1990, Traynelis & Cull-Candy 1990). On the contrary, several other 
works suggest that acidosis activates acid sensing ion channels (ASICs) which results in 
intracellular Ca2+ overload causing acidotoxicity independent of NMDA mediated 
excitotoxicity (Xiong et al. 2004, Yermolaieva et al. 2004).
Although previous in vitro and in vivo studies show that brain ischemia triggers 
excessive glutamate release (Benveniste et al. 1984, Mitani et al. 1994), activation of 
NMDA receptors (Choi 1992) and concomitant tissue acidosis (Siemkowicz & Hansen 
1981), it remains elusive how the acidotic component interacts with glutamate-mediated 
excitotoxicity. Challenges in deciphering the interaction between these two mechanisms 
are overcome in the current study by use of a novel in vitro microperfusion technique in 
which pH is manipulated independently from oxygen glucose deprivation (OGD).
The present study tested the hypothesis that low pH during OGD blocks NMDA 
mediated excitotoxicity but produces acidotoxicity via ASIC1a. We utilized acute rat
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hippocampal slices to ascertain the time course of injury from OGD with and without 
acidosis as well as acidosis alone. Cell death subsequent to these manipulations was 
assessed by lactate dehydrogenase (LDH) release (Koh & Choi 1987).
2.3 Methods
2.3.1 Animals
Adult Male Sprague Dawley rats (Simonsen labs, Gilroy, CA; age 3-4 months, 250­
400 g) were used for all experiments. The animals used in this study were housed in 
University of Alaska Fairbanks Animal Resource Center (ARC), fed ad libitum, and kept 
under a 12:12 light: dark cycle with lights on at 0700 and off at 1900. During housing, 
animals were monitored once daily for health status. No adverse events were observed 
during housing. All experimental procedures were approved by the University of Alaska 
Fairbanks Institutional Animal Care and use Committee (IACUC), performed in 
accordance with the strict guidelines of the 8th edition of the Guide for the Care and Use 
of Laboratory Animals published by the US National Institutes of Health. Research were 
conducted in accordance with ARRIVE guidelines for reporting animal research (Kilkenny 
et al. 2010).
2.3.2 Acute hippocampus slice preparation
Slices were prepared between 0800 and 1030. Animals were anesthetized using 
5% (v/v) isoflurane with medical graded O2 at a constant flow rate of 1.5 L/min. Once 
unresponsive, the animals were euthanized via rapid decapitation and their brains quickly 
removed. The whole brain was then placed in ice chilled, oxygenated HEPES buffered 
artificial cerebral spinal fluid (HEPES-aCSF) containing 120 mM NaCl, 20 mM NaHCO3,
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6.68 mM HEPES acid, 3.3 mM HEPES sodium salt, 5.0 mM KCl, 2.0 mM MgSO4 (pH 7.3 
- 7.4) to attenuate edema during the course of slicing and incubation. Rapidly dissected 
hippocampi were embedded in 2.5 % agar and transverse hippocampal slices. 
Approximately 10 mm were discarded from both ends and 400 jm  thick slices from each 
hippocampus were cut at approximately 2°C in oxygenated HEPES-aCSF using a 
Vibratome® 1000plus sectioning system (The Vibratome Company, St. Louis, MO). The 
slices were then transferred to a brain slice keeper (Scientific Systems Design Inc., 
Mississauga, Ontario, CA) and allowed to recover for 1-1.5 h at room temperature in 
HEPES-aCSF bubbled continuously with 95% O2/ 5% CO2 before transferring to 
experimental conditions as indicated.
2.3.3 Microperfusion chamber
To address the time course of injury, treatment was applied using an in vitro 
microperfusion technique described previously (Kirschner et al. 2009). Briefly, after 1-1.5 
h recovery as described above, individual slices were transferred gently to microperfusion 
chambers and lids sealed. The 4-8 parallel chambers were perfused with artificial 
cerebrospinal fluid (aCSF), pH 7.3 containing 120 mM NaCl, 45 mM NaHCO3, 10 mM 
glucose, 3.3 mM KCl, 1.2 mM NaH2PO4, 2.4 mM MgSO4, 1.8 mM CaCl2 bubbled with 
95% O2 /5% CO2 and submerged in aCSF bath at 36°C (±0.2°C) at a flow rate of 7 |jL/min. 
Sampling began 75 min after submerging the sealed chambers to allow adequate time 
for stabilization of neurochemical efflux. At 15 min interval, perfusates (7 jL  /min X 15 
min =105 jL ) was collected and analyzed as indicated. The volume of each chamber was 
estimated at 35^L based on dimensions of 9*5*0.7 mm (L*W*H) with 0.3-mm deep 
microchannels. Approximately half of this volume was displaced by the 400^m thick slice.
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2.3.4 Treatment / injury conditions
To model ischemia-induced alterations in the ionic microenvironment in the 
hippocampus, acute hippocampal slices were exposed to 30 min of one of the four 
treatments: (1) aCSF, pH 7.3, (2) OGD, pH 7.3 (glucose-oxygen free aCSF), (3) aCSF, 
pH 6.4 (120 mM NaCl, 7.03 mM NaHCOs, 10 mM glucose, 3.3 mM KCl, 1.2 mM NaH2PO4,
2.4 mM MgSO4 1.8 mM CaCl2, (4) OGD, pH 6.4 (glucose-oxygen free low pH aCSF). 
Acidosis was induced with a pH of 6.4 based on previous studies that suggest 
hippocampal homomeric ASIC1a peak current showed a high sensitivity to pH 6.4 (pH0.5 
= 6.4 and nH = 1.65 for ASIC1a) (Baron et al. 2001). Ischemia-induced alteration was 
made by switching the solution (from aCSF pH 7.3 to OGD pH 7.3, aCSF, pH 6.4 and 
OGD, pH 6.4) 8 min prior to the start of insult, the time it takes to completely replace the 
solution in the chamber with a flow rate of 7 jL/min. All aCSF solutions were equilibrated 
with 95% O2 and 5% CO2 whereas the OGD solutions were equilibrated with 5% CO2 and 
95% N2, for a minimum of 1 h until pH stabilized in the desired range. The osmolarity of 
these solutions was between 290 and 300 mOsm. The PO2 in OGD solution varied from 
0-2.9 mmHg with an average for 6 determinations of 1.1 mm-Hg as measured using a 
miniature Clark-style electrode (Instech Laboratories, Plymouth Meeting, PA). Collected 
fractions were analyzed for cell death (LDH release) on the day of collection. Remaining 
volume was kept at -80°C for subsequent analysis. For evaluating the effect of 
NMDAR and ASIC1a on OGD or acidosis mediated cellular injury in acute hippocampal 
slices, the respective inhibitors were added throughout the experiment (during 
pretreatment, the insult phase and reperfusion). MK-801 (noncompetitive NMDAR 
antagonist, 100 jM , Sigma-Aldrich, St Louis, MO), Amiloride (non-specific ASIC inhibitor,
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100 jM , Cayman chemical, Ann Arbor, MI), Psalmotoxin (PcTX1 - specific ASIC1a 
inhibitor, 50 nM, Abcam, Cambridge, MA) were used for NMDAR and ASIC 
manipulations.
2.3.5 Assessment of cellular injury- LDH measurement
Cell injury was assessed by the measurement of LDH release (Koh & Choi 1987). 
Following collection of perfusates every 15 min during the course of the experiment, 50 
j l  of perfusate was transferred to 384-well plates and mixed with 50 j l  reaction solution 
provided by the LDH assay kit (Cayman chemical, Ann Arbor, MI). Optical density was 
measured at 490 nm 60 min later, using a microplate reader (Epoch Microplate 
Spectrophotometer, BioTek, Winooski, VT). Background absorbance at 620nm was 
subtracted. The LDH release was quantified as an arbitrary unit per mg of protein (Bio­
Rad protein assay kit, Hercules, CA) and represented as a fraction of baseline LDH 
release. The maximal releasable LDH was also obtained by treating the slices with 1% 
NP-40 lysis buffer (50 mM Tris-HCl, 0.5% sodium deoxycholate, 0.1% SDS, 1% Igepal, 
150 mM NaCl, 0.05% Triton X-100) at the end of each experiment.
2.3.6 Assessment of metabolic efflux
Glutamate and aspartate were analyzed by capillary electrophoresis. Perfusates 
were derivatized as described previously (Kirschner et al. 2007, Kirschner et al. 2009) to 
form highly fluorescent cyanobenz[f]isoindole amino acids (CBI-amino acids). Briefly, 2 
^L thawed perfusate was reacted with 2 ^L 2 mM naphthalene-2,3-dicarboxaldehyde 
(NDA) in methanol and 2 ^L NaCN (5.5 mM) in 60 mM sodium tetraborate. Cyanide 
solution contained 3^M D-amino adipic acid as internal standard. Samples were reacted 
at room temperature for approximately 20 min prior to analysis. CE-LIF was performed
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on a custom in-house-built instrument using a 420-nm diode laser, 490-nm bandpass 
filter, and PMT for LIF detection. Samples were injected onto a bare fused silica capillary 
of dimensions 25 cm x 25 ^m (22.5 cm to detection window) for 1-3 sec at 380-mbar 
vacuum and separated by using positive polarity (20 kV). Separation buffer optimized for 
analysis of L-glutamate and L-aspartate is a 50mM sodium tetraborate background 
electrolyte (BGE) adjusted to pH 9.3. BGE additionally contained 1.0 mM p-cyclodextrin 
to decrease sample run time for glutamate and aspartate analysis. The addition of p- 
cyclodextrin allowed for baseline resolution of glutamate, aspartate, and the internal 
standard in less than 2 min. PeakFit software (SeaSolve Software Inc., Framingham, MA) 
was used to process raw data and quantify peak areas in all experiments based on a 
Gaussian peak shape for each analyte. Linear calibration curves were constructed for 
glutamate and aspartate as a function of concentration verses the peak area ratio 
(analytes area/internal standard area). Efflux of analytes was quantified as a 
concentration of glutamate or aspartate normalized to total protein for the slice used in 
the efflux experiment and represented as a fraction of baseline glutamate or aspartate 
release.
2.3.7 Determination of ATP and adenosine
ATP was determined after bath application of OGD or normoxic conditions as 
described previously.(Christian et al. 2008) In brief, slices were incubated in either aCSF 
or OGD solution and collected at the time point indicated. From each treatment 
conditions, 3 hippocampal slices were transferred to a flat-bottomed microfuge tube 
containing 200 jL  of ice-cold 5% trichloroacetic acid, sonicated (8 pulses), centrifuged at 
16,000 g for 1 min at 4°C. Supernatant was then collected and assayed for ATP using
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ENLITEN ATP assay (Promega, Madison, WI). The pellets were further reconstituted with 
200 jL  1M NaOH and protein concentration was analyzed (Bio-Rad protein assay kit, 
Hercules, CA). ATP level was represented as a concentration of ATP normalized to total 
protein for the slices.
Adenosine level was determined using HPLC as previously reported with slight 
modifications. In brief, 2mM acetic acid (pH 4.0) in 7% acetonitrile constitute the mobile 
phase having a flow rate of 20 ^L/min produced by a PrimeLine pump (ASI, Analytical 
Scientific Instruments, El Sobrante, CA). The process of separation was achieved by a 
BAS microbore column (MF-8949; 1x 100 mm and 1x14mm guard column, with C18 
packing of 3-^m particle size, BASi, West Lafayette, IN), which was attached directly to 
the injector (Rheodyne 9125, Rohnert Park, CA) and to the UV detector (Waters 2487 UV 
detector, outfitted with a Waters microbore cell kit, Waters Corporation, Milford, MA). 
Adenosine was detected at a wavelength of 258 nm. Chromatographic data were 
recorded with a Peak Simple Chromatography data system (SRI, model 203, SRI 
Instruments, Torrance, CA) and the peak areas of microperfusion samples were 
compared to the peak areas of adenosine standards (10^L of 50nM) for quantification. 
The detection limit of the assay was 33 fmol (based on a signal-to-noise ratio of 3:1). 
Concentration is expressed as nM and retention time for adenosine was between 11.0 
and 11.3min.
2.3.8 Statistical analysis
A priori power analysis (using G*Power software) was performed to estimate 
sample size needed to yield 80% power for detecting a therapeutically significant effect 
of treatment. No animal was excluded from the study. Slices from animals were randomly
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assigned to treatment and control groups without prior knowledge to the treatment 
conditions. Data processing and statistical analyses were performed using Microsoft 
Office Excel 2010 and Graph PadPrism6. Data were analyzed with one-way or two-way 
ANOVA with repeated measures. Significant main effects or interactions were followed 
by t-tests with Bonferroni's correction. Data are expressed as mean ± SEM, and P < 0.05 
was considered as statistically significant.
2.4 Results and discussion
2.4.1 OGD injury via microperfusion approach resembles similar disruption in energy 
homeostasis and excitatory neurotransmitter efflux that mimics in vivo I/R injury.
During cerebral ischemia in vivo, acidotoxicity and excitotoxicity occur 
concomitantly and it is unclear how these two mechanisms interact. Moreover, it is not 
possible to manipulate acidosis to decipher how it interacts with excitotoxicity. Traditional 
in vitro slice preparations do not produce the same changes in the extracellular milieu as 
what occurs in vivo because of rapid washing with a highly diluted bath solution (Yao et 
al. 2007). The finding of this study involves using a novel microperfusion technique that 
allows for time resolved study of cell death and manipulation of pH with and without OGD 
thus allowing for study of the interaction between acidosis and OGD-induced injury. The 
advantages of this model include the opportunity for temporal resolution of injury as well 
as overflow of metabolites and neurotransmitters and to manipulate each of the 
components of the ischemic cascade to better understand interactions. With the 
microperfusion approach we measured only LDH release as a marker of cell death. 
Cytosolic lactate dehydrogenase release following injury is due to membrane disruption 
that correlates with cell death. In the present study, for the first time we have monitored
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continuous LDH release in an acute slice preparation where it allows for observation of 
the time course of membrane disruption. Here, we investigated the effect of in vitro 
ischemia like condition (OGD) exposure on energy homeostasis (Dale & Frenguelli 2009) 
and excitotoxic neurotransmitter efflux (Benveniste et al. 1984), a hallmark of ischemic 
injury in acute hippocampal slices from rat. Results show that exposure of acute 
hippocampal slices to 30 min OGD insult resulted in a significant depletion in ATP levels. 
Slices treated with OGD showed a significant drop in ATP when compared to control 
slices. Slices with OGD showed no signs of ATP restoration even after 3 hours of 
reperfusion (Figure 2.1 A). This indicates that energy homeostasis is highly dysregulated 
due to OGD exposure. To further validate the disruption of energy homeostasis in 
correlation to adenosine, we investigated the level of adenosine efflux upon OGD 
exposure. Slices exposed to 30 min of OGD showed significant efflux in extracellular 
adenosine when compared to the control slices. The adenosine level returned to baseline 
within 15 min of the onset of reperfusion (Figure 2.1 B). From our results, we conclude 
that when acute hippocampal slices are subjected to 30 min of OGD insult, they release 
extracellular adenosine produced from rapid degradation of ATP due to ischemic-like 
conditions.
We next investigated the effect of OGD exposure on excitotoxic neurotransmitter 
efflux such as glutamate and aspartate. Consistent with previous in vivo studies (Mitani 
et al. 1994, Cui et al. 1999), perfused slices exposed to OGD injury for 30 min released 
glutamate (62-fold increase over basal level) (Figure 2.2 A). Similarly, aspartate efflux 
also increased during OGD (11.4-fold increase over basal level) (Figure 2.2 B). After the 
onset of reperfusion, the glutamate levels returned to baseline levels within 60 min,
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aspartate returned to baseline levels within 45 min.
The observations reported herein validate the microperfusion approach. 
Dysregulation in energy homeostasis and excessive release of excitatory 
neurotransmitters are decisive for the development of excitotoxicity during cerebral 
ischemia. With our approach, when hippocampal slices are subjected to OGD, tissue ATP 
declines and adenosine, glutamate, and aspartate are released into the extracellular 
space. These observations are in accord with previous in vitro and in vivo studies that 
supports similar energy dysregulation (Latini & Pedata 2001, Dunwiddie et al. 1997), and 
excitatory neurotransmitter release during cerebral ischemia in vivo and OGD in vitro 
(Benveniste et al. 1984, Mitani et al. 1994, Hagberg et al. 1985, Butcher et al. 1990, 
Shimizu et al. 1993).
2.4.2 OGD or acidosis causes injury during insult rather than during reperfusion
How much injury occurs during the ischemic and reperfusion phases continues to 
be controversial in both experimental animal and clinical studies (Kloner 1993). Intrinsic 
to ischemia reperfusion injury is the concept that harmful events are occurring during both 
ischemia and reperfusion (Jaeschke 1999, Kalogeris et al. 2012). With the microperfusion 
approach, we monitored the timing of injury to decipher whether cell death was due to 
"insult” (OGD or low pH) or to "reperfusion”. In these experiments, reperfusion was 
modeled by returning oxygen and glucose or by returning pH to 7.3. We varied the 
duration of insult between 15, 30, and 45 min with the expectation that delayed return of 
oxygen and glucose or delayed return to pH 7.3 would delay LDH release if injury was 
caused by the modeled reperfusion phase. Delaying onset of modeled reperfusion (for 15 
min, 30 min, or 45 min) or the return to pH 7.4 from pH 6.4 (for 15 min, 30 min, or 45 min)
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did not delay the peak time of LDH release. However, the magnitude of injury was 
increased (Figure 2.3 A-B). This indicates that injury was caused by the primary OGD or 
low pH insult and not by modeled reperfusion.
One study suggests that low pH causes detrimental effect during reperfusion (Gu et 
al. 2010). However, extracellular pH decreases immediately (Simon et al. 1985) after the 
onset of ischemia and is restored to the normal physiological range upon reoxygenation 
(Regli et al. 1995). Given this time course of acidosis, a sustained severe acidosis during 
the reperfusion phase is unlikely. When acidosis was prolonged during the low pH insult 
phase, injury increased in magnitude but was not offset by the time of reperfusion. A 
similar observation was made with OGD insult. Thus, with regards to timing of acidosis, 
our experimental set-up mimicked the in vivo scenario and shows that injury associated 
with OGD or low pH occurs during insult rather than during reperfusion.
2.4.3 Low pH delays OGD injury and shows injury independent of OGD insult
Buffering of the OGD solution during in vitro experiments eliminates the acidotic 
component that occurs during cerebral ischemia in vivo. To study the interaction between 
acidosis and OGD on cellular injury, the pH of the OGD solution was adjusted from 7.3 to
6.4. OGD at pH 6.4 decreased and delayed LDH release as compared to OGD at 
physiological pH 7.3. Results show that OGD with low pH shows similar time course of 
injury as observed with low pH alone. With similar time course of injury, no significant 
statistical differences were observed at any given time point between OGD with low pH 
and low pH alone (Figure 2.4 A). This suggests that when low pH is introduced along with 
OGD, low pH overrides OGD mediated injury. When the total injury represented by the 
area under the curve was considered, LDH released by pH 6.4 was not different from
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LDH released by OGD, pH 7.3 or by OGD pH 6.4 (Figure 2.4 B). This indicates that low 
pH delays OGD injury, but on its own, causes injury that is as deleterious as OGD.
2.4.4 Injury caused by OGD insult is due to NMDAR activation whereas low pH injury is 
ASIC1a mediated
We next ask whether the delay in injury caused by acidosis is due to modulation of 
NMDAR. While application of NMDAR antagonist (MK-801) decreased LDH release in 
groups subjected to OGD, pH 7.3 (Figure 2.5 A), no significant effect on LDH release was 
observed in slices subjected to acidosis, pH 6.4 (Figure 2.5 B) or OGD with acidosis, pH
6.4 (Figure 2.5 C). This suggests that OGD injury at physiological pH involves NMDAR 
activation whereas injury associated with acidosis alone or acidosis in combination with 
OGD is independent of NMDAR mediated excitotoxicity.
Because acidosis contributes to cell death independent of OGD (Figure 2.4 A-B), 
we next explored the role of ASICs. We expected that targeting the ASIC1a with specific 
and non-specific blocker would attenuate pH 6.4-mediated cell death. As illustrated in 
Figure 2.6 A-B, continuous perfusion of 100 ^M amiloride (nonspecific ASIC blocker 
which acts by blocking the channel pore) during acidosis, pH 6.4 and OGD pH 6.4 tended 
to decrease LDH release; however, failed to produce a statistically significant effect. Next, 
we tested the effect of Psalmotoxin (PcTx), a specific blocker of Ca2+-permeable 
homomeric ASIC1a. Application of PcTx (50 nM) blocked aCSF pH 6.4 and OGD pH 6.4- 
induced LDH release (Figure 2.6 C-D). This result supports the involvement of ASIC1a in 
low pH mediated injury.
Results reported herein demonstrate that delayed injury was solely due to ASIC1a 
activation since NMDAR blockade had no effect on OGD-induced cell death in the
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presence of proton load. No decrease in LDH release with NMDAR blockade in presence 
of proton load could also be due to high concentration of MK-801(100 ^M). The higher 
concentration might have compromised the specificity of MK-801 on the NMDAR receptor 
favoring non-specific binding that masked the neuroprotective effect of NMDAR blockade. 
Since, with the same concentration of MK-801, we observed decreased LDH release in 
groups subjected to OGD at pH 7.3, we believe that the non-specificity associated with 
high concentration of MK-801 did not confound the results of our study. Blocking the 
NMDAR with MK-801 will block the NR2B-NMDARs/CaMKII cascade described 
previously to enhance ASIC1a-mediated current (Gao et al. 2005). The present work 
cannot rule out a NR2B-specific pathway, however, injury caused by low pH alone or with 
OGD did not depend on a NR2B/CaMKII pathway since MK-801 blocks all NMDARs 
including those that contain NR2B.
Preclinical in vivo studies and clinical trials have also failed to show neuroprotective 
effects of MK-801 (Ellison 1995, LeBlanc et al. 1991, Horvath et al. 1997). The 
interpretation that low pH abolishes NMDAR mediated excitotoxicity contrasts with other 
studies where authors have suggested that OGD-induced cell death is due to NMDAR, 
but delayed by pH dependent inhibition of NMDA (Kaku et al. 1993, Giffard et al. 1990, 
Sapolsky et al. 1996). Here we show that delayed injury is solely due to ASIC1a, that is 
unmasked by complete attenuation of excitotoxicity.
This interpretation is consistent with prior work showing that mild acidosis during 
brain ischemia protects against excitotoxic injury by modulating glutamate-mediated 
excitotoxicity (Tombaugh & Sapolsky 1990, Kaku et al. 1993). These results also support 
prior work showing that increased load of proton due to acidosis (Rehncrona et al. 1981,
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Kalimo et al. 1981) activates a distinct family of ligand-gated channels, the acid-sensing 
ion channels, ASICs (ENaC/Deg superfamily) (Waldmann et al. 1997, Baron et al. 2002, 
Alvarez de la Rosa et al. 2003) and mediates injury unrelated to NMDAR. The role of 
ASIC1a activation during acidotoxicity has been previously confirmed in in vivo studies. 
Furthermore, ASIC1a knock-out or pharmacological blockade of ASIC1a attenuates injury 
associated with brain ischemia. Our present results with selective antagonism of ASIC1a 
with PcTX1 are consistent with the role of ASIC1a in ischemic damage as previously 
reported. The less robust ability of amiloride to attenuate the effect of low pH could be 
due to dose. The IC50 of amiloride to inhibit ASICs is between 5 and 100 qM (Baron & 
Lingueglia 2015). In this dose range, amiloride is not specific for ASIC1a. For example, 
at 100 qmol/L, the concentration used in this study, amiloride enhances the sustained 
current evoked in cells transfected with ASIC3 (Yagi et al. 2006, Li et al. 2011). At slightly 
higher concentrations amiloride affects other targets including other ion channels (e.g., 
epithelial Na+ channel and calcium channels) and exchangers (e.g., Na+/H+ and Na+/Ca2+) 
(Frelin et al. 1988, Kleyman & Cragoe 1988). Thus, it was not feasible to test a higher 
dose of amiloride without confounding results by nonspecific effects. For this reason, we 
tested the specific ASIC1a blocker PcTX1. This specific blocker of ASIC1a completely 
abolished LDH release caused by both low pH alone and low pH with OGD.
Both activation of NMDAR and ASIC1a causes high influx of intercellular Ca2+ that 
causes cell damage. Previous studies provide strong evidence that ASIC1-a mediated 
increase in Ca2+ influx could contribute to Ca2+ overload, an important mechanism of cell 
damage and death in ischemia (Yermolaieva et al. 2004, Xiong et al. 2004). Others have 
shown that Ca2+ is not required for ASIC1a - mediated cell death (Wang et al. 2015). Our
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study of the interaction of OGD and pH was enabled through the use of a novel 
microperfusion technique. This in vitro preparation allowed for independent manipulation 
of OGD and pH and for time resolved assessment of cell death. The approach was 
validated by demonstrating that it mimics an in vivo cerebral ischemia scenario in terms 
of dysregulation in energy homeostasis and excessive release of excitatory 
neurotransmitters, hallmarks of ischemic injury. With the microperfusion approach, we 
measured only LDH release as a marker of cell death throughout the slice and cannot 
distinguish between sub regions of the hippocampus or between cell type. LDH release 
is a standard approach to monitor cell death (Chan et al. 2013) which is released from 
the cytosol due to membrane disruption and not due to metabolic changes related to 
OGD. In the present study, for the first time we have monitored continuous LDH release 
in an acute slice preparation where it allows for observation of the time course of 
membrane disruption from the entire slice. We interpret membrane disruption as an early 
indicator of cell death. Other markers of cell death such as propidium iodide (PI) staining 
produce high background due damage of the cells at the surface during acute slice 
preparation. Results here, based on time resolved release of LDH are consistent with 
prior work from this laboratory, based on PI staining in acutely prepared or short-term 
cultured slices (Christian et al. 2008, Ross et al. 2006). Although slices are incubated until 
high baseline levels of LDH reach a stable minimum, there is a possibility that acutely 
injured cells on the surface of the slice are affected more than cells at the center of the 
slice. Thus, the novel microperfusion method developed in our laboratory (Kirschner et 
al. 2009) for study of cell death in acute, adult slices overcomes the limitations of methods 
used in prior studies where high baseline cell death may compromise interpretation.(Ross
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et al. 2006, Christian et al. 2008) The microperfusion approach minimizes background 
cell death caused by trauma at the surface of the slice by capturing LDH release from the 
entire slice. The microperfusion approach also monitors the time course of injury as well 
as the overflow of metabolites and neurotransmitters. Despite these advantages over 
other in vitro approaches to monitor cell death, we acknowledge that the slice preparation 
differs from the in vivo scenario (Cho et al. 2007, Saeidnia et al. 2015). However, the 
microperfusion approach gives superior control over the extracellular environment that 
could not be achieved in vivo. Here we show that LDH release during OGD or low pH 
insult reaches a maximum peak and then subsides. We suggest that the decay in the 
LDH signal peak is not a consequence of dilution because flow rate and sampling rate 
are constant throughout the experiment. Furthermore, the waning in LDH release is not 
due to depletion of LDH since no difference in total LDH content was observed in slices 
subjected to aCSF, OGD or low pH treatment (Data not shown). Further study will be 
required to understand why LDH release subsides over time.
Previous in vitro studies performed in cell culture or in cultured post-natal brain 
tissue (Giffard et al. 1990, Gu et al. 2010, Tang et al. 1990, Lushnikova et al. 2004) 
suggest that cell death typically occurs 4 hours after OGD treatment. By contrast, our 
study shows that 30 minutes of insult is sufficient to cause immediate membrane 
disruption marked by LDH release. It is to be noted that there is a difference in how each 
model responds to a commonly studied ischemic-like paradigm, oxygen-glucose 
deprivation. Previous studies show that acute slice viability is affected by OGD lasting as 
little as 10 min (Small et al. 1995, Taylor et al. 1999) whereas, organotypic hippocampal 
slice cultures tolerate a much longer duration of challenge (Lushnikova et al. 2004,
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Sullivan et al. 2002, McManus et al. 2004). We chose to use acute slices, because it 
allows for study of cell death in adult tissue not possible with organotypic hippocampal 
slice culture. Organotypic cultures differ from adult brain slices in several ways such as 
influence of age (adult vs. neonatal) which may influence the mechanisms of resistance 
to injury, the proportion of neurons to glia, synaptic connections between neurons, neural 
circuitry that influences metabolic demand of the tissue and maturity of the neurons 
studied (Lein et al. 2011, De Simoni et al. 2003, Lossi et al. 2009). Thus, study in cultured 
cells or post-natal tissue may not reflect mechanisms operative in adult brain tissue.
2.5 Conclusion
This paper reports several important findings using a novel microperfusion 
technique that for the first time provides time-resolved observations of excitotoxicity and 
acidotoxicity in an in vitro model of cerebral ischemia/reperfusion in adult hippocampus. 
Firstly, our results demonstrate that injury associated with acidosis (pH 6.4) or OGD (pH
7.3) occurs during insult rather than during the reperfusion phase. Secondly, we show 
that acidosis combined with OGD delays OGD injury. Finally, we show that when OGD is 
combined with acidosis as occurs in vivo, acidotoxicity mediated via ASIC1a occurs but 
low pH abolishes NMDAR mediated excitotoxicity.
In conclusion, we show that acidosis eliminates the NMDAR contribution to OGD- 
induced cell death but causes injury through an ASIC1a mediated mechanism. Although 
this study resolves controversy surrounding the interplay between NMDA and ASIC1a, 
the translational potential of ASIC1a may be limited. Acidosis may have longer-term 
effects not addressed here. Pignataro et al., 2007 observed protective effects when an 
ASIC1a antagonist was applied as late as 5 h after occlusion in vivo (Pignataro et al.
54
2007). Other mechanisms such as uncoupling of NADPH oxidase from NMDAR activation 
by intracellular acidosis (Lam et al. 2013) or acidosis mediated reorganization of 
mitochondrial efficiency (Khacho et al. 2014) could also contribute to longer-lasting 
intercellular acidosis mediated protective effects. Identification and understanding of the 
interaction between acidotoxicity and NMDAR mediated excitotoxicity point towards a 
better mechanistic approach in design of an effective therapeutic strategy for brain 
ischemia caused by stroke and cardiac arrest.
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Figure 2.1: Integrity of acute slices is validated from observation that OGD injury causes 
disruption in energy homeostasis.
(A) Levels of whole tissue ATP were determined over a course of time using bath 
application in normoxic slices or slices treated with OGD. Grey bar indicates 30 min insult 
period. *p< 0.05 OGD, n= 4 versus aCSF, n= 4. Triplicate slices were pooled per 
treatment per time point, n= 4 animals. (B) Level of adenosine efflux monitored in slices 
subjected to 30 min aCSF or OGD using the microperfusion approach. Grey bar indicates 
30 min insult period. *p< 0.05 represents adenosine efflux normalized to baseline (n= 7 
control slices, 4 animals; n= 7 OGD slices, 4 animals).
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Figure 2.2. Oxygen glucose deprivation triggers efflux of excitatory amino acids similar to 
in vivo brain ischemia.
Time-dependent efflux in rat hippocampal slices induced by 30 min OGD insult. (A, B) 
Glutamate and aspartate efflux in hippocampal slices during OGD insult (n = 17 slices 
from 6 animals) and during aCSF (aCSF, pH = 7.3-7.4, n = 16 slices from 6 animals). 
Gray bar indicates insult period. Data shown are normalized to baseline (glutamate 
(pM/mg protein): aCSF = 3.7; OGD= 4.7; aspartate: aCSF = 1.2; OGD = 1.9); *p < 0.05 
for OGD versus aCSF.
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Figure 2.3. OGD or low pH acidosis causes injury during insult rather than during 
reperfusion.
Time course of LDH release induced by (A) OGD, pH 7.3 insult for 15 min (n = 4 slices), 
30 min (n = 5 slices), or 45 min (n = 5 slices) followed by reperfusion (aCSF, pH = 7.3­
7.4); Significant differences are represented as ap < 0.05 versus OGD, pH 7.3 for 15 min, 
bp < 0.05 versus OGD, pH 7.3 for 30 min. (B) aCSF, pH 6.4 insult for 15 min (n = 3 slices), 
30 min (n = 3 slices) or 45 min (n = 3 slices) followed by reperfusion (aCSF, pH = 7.3). 
Significant differences are represented as ap < 0.05 versus aCSF, pH 6.4 for 15 min, bp 
< 0.05 versus aCSF, pH 6.4 for 30 min. Gray bar indicates insult period. "I” indicates insult 
phase (I15 = 15 min, I30 = 30 min, I45 = 45 min). All data were normalized to baseline 
measured as LDH release per mg of protein (15 min OGD, pH 7.3 = 0.315, 30 min OGD, 
pH 7.3 = 0.250, 45 min OGD, pH 7.3 = 0.359; 15 min aCSF, pH 6.4 = 0.163, 30 min aCSF, 
pH 6.4 = 0.169, 45 min aCSF, pH 6.4 = 0.162).
58
O iJ"  o"
Figure 2.4. Acidosis (pH 6.4) delays OGD induced injury but produces injury independent
of OGD.
(A) Shows time course of LDH release as a marker of cell death in acute hippocampal 
slices exposed to OGD, pH 7.3 (n= 23 slices from 23 animals); OGD, pH 6.4 (n=17 slices 
from 9 animals) or aCSF, pH 6.4 (n=28 slices from 14 animals). Grey bar indicates insult 
period. Data were normalized to baseline measured as LDH release per mg of protein 
(aCSF, pH 7.3 = 0.276; OGD, pH 7.3 = 0.324; aCSF, pH 6.4 = 0.174; OGD, pH= 0.244). 
Note that acidosis (pH 6.4) during OGD delays OGD induced cell death. ap< 0.05 versus 
aCSF (pH 7.3), bp< 0.05 versus aCSF (pH 6.4), cp< 0.05 versus OGD (pH 6.4). Two-way 
ANOVA repeated measure with Bonferroni correction; means ± SEM. (B) Total LDH 
release represented by area under the curve. Note that the overall injury caused by pH
6.4 is as large as OGD or OGD with pH 6.4. *p<0.05 versus aCSF, pH 7.3 (n= 19).
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Figure 2.5. OGD insult is largely due to NMDAR activation whereas low pH injury is 
independent of NMDAR-mediated cytotoxic cascade.
(A) Slices incubated with 100 ^M MK-801 followed by 30 min OGD, pH 7.3 (n= 6 slices, 
3 animals) insult and LDH release was compared to OGD, pH 7.3 (n=23 slices, 23 
animals). (B-C) Slices pre-incubated with 100 ^M MK-801, exposed to either aCSF pH
6.4 (n=12 slices, 3 animals) or OGD pH 6.4 (n=12 slices, 4 animals) and LDH release 
was compared to aCSF pH 6.4 (n=28 slices, 14 animals) or OGD pH 6.4 (n=17 slices, 9 
animals). Grey bar indicates insult period and dotted line indicates presence of MK-801. 
Data normalized to baseline measured as LDH release per mg of protein (aCSF, pH 7.3 
= 0.276; OGD, pH 7.3 = 0.324; OGD + MK-801 = 0.677). *p< 0.05 versus OGD, pH 7.3; 
+p< 0.05 versus aCSF, pH 7.3.
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Figure 2.6. ASICIa is partly responsible for mediating low pH mediated injury.
LDH measurement in response to aCSF pH 6.4 (n= 28) and during OGD pH 6.4 (n= 17) 
in presence of (A) aCSF pH 6.4 + 100pM AMI (n=20 slices, 7 animals), (B) OGD pH 6.4 
+ 100pM AMI (n= 9 slices, 5 animals), (C) aCSF pH 6.4 + 50 nM PcTx (n= 12 slices, 3 
animals), (D) OGD pH 6.4 + 50 nM PcTx (n= 12 slices, 3 animals). Grey bar indicates 
insult period and dotted line indicates presence of AMI or PcTx. Note that blocking 
ASIC1a channels with PcTx1 significantly attenuates LDH release in both aCSF pH 6.4 
and OGD pH 6.4 groups. Data were normalized to baseline measured as LDH release 
per mg of protein (aCSF pH 6.4 = 0.174; OGD pH 6.4= 0.244; aCSF pH 6.4 + AMI = 
0.361, aCSF pH 6.4 + PcTx = 0.482, OGD pH 6.4 + AMI = 0.398, OGD pH 6.4 + PcTx = 
0.299). Significant differences indicated as *p< 0.05 versus aCSF pH 6.4; #p< 0.05 versus 
OGD, pH 6.4.
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Figure 2.7 Graphical abstract. Acidosis overrides NMDA mediated excitotoxicity.
Schematic diagram illustrates that invitro ischemic like state (OGD) initiates a cascade of 
events leading to cell death wherein low pH abolishes OGD injury induced by NMDAR 
activation but causes cell death (LDH release) via ASIC1a activation. Green solid line 
represents ischemic cascade induced by OGD, green dotted line not addressed in this 
study but supported by others, red arrow represents low pH mediated elimination of 
NMDAR contribution to OGD-induced cell death.
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Chapter 3: Arctic ground squirrel hippocampus tolerates oxygen glucose deprivation 
independent of hibernation season even when not hibernating and after ATP depletion,
acidosis, and glutamate efflux2
3.1 Abstract
Cerebral ischemia/reperfusion (I/R) triggers a cascade of uncontrolled cellular 
processes that perturb cell homeostasis. The arctic ground squirrel (AGS), a seasonal 
hibernator resists brain damage following cerebral I/R caused by cardiac arrest and 
resuscitation. However, it remains unclear if tolerance to I/R injury in AGS depends on 
the hibernation season. Moreover, it is also not clear if events such as depletion of ATP, 
acidosis, and glutamate efflux that are associated with anoxic depolarization are 
attenuated in AGS. Here, we employ a novel microperfusion technique to test the 
hypothesis that tolerance to I/R injury modeled in an acute hippocampal slice preparation 
in AGS is independent of the hibernation season and persists even after glutamate efflux. 
Acute hippocampal slices were harvested from summer euthermic AGS, hibernating 
AGS, and interbout euthermic AGS. Slices were subjected to oxygen glucose deprivation 
(OGD), an in vitro model of I/R injury to determine cell death marked by lactate 
dehydrogenase (LDH) release. ATP was assayed using ENLITEN ATP assay. Glutamate 
and aspartate efflux was measured using capillary electrophoresis. For acidosis, slices
2 Published as Bhowmick S, Moore JT, Kirschner DL, Drew KL. "Arctic ground squirrel 
hippocampus tolerates oxygen glucose deprivation independent of hibernation season 
even when not hibernating and after ATP depletion, acidosis and glutamate efflux.” J 
Neurochem. 2017 Feb 21. doi: 10.1111/jnc.13996. [Epub ahead of print]. PubMed PMID: 
28222226
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were subjected to pH 6.4 or ischemic shift solution (ISS). Acute hippocampal slices from 
rats were used as a positive control, susceptible to I/R injury. Our results indicate that 
when tissue temperature is maintained at 36°C, hibernation season has no influence on 
OGD-induced cell death in AGS hippocampal slices. Our data also show that tolerance 
to OGD in AGS hippocampal slices occurs despite loss of ATP and glutamate release, 
and persists during conditions that mimic acidosis and ionic shifts, characteristic of 
cerebral I/R.
3.2 Introduction
Brain tissue is highly vulnerable to ischemic injury in almost all species wherein 
occlusion of cerebral arteries causes either a transient or a permanent decrease in blood 
flow to the brain. This, in part, leads to tissue hypoxia (reduced O2) wherein the tissue is 
unable to extract adequate O2, the partial pressure of O2within the tissue falls leading to 
a reduction in mitochondrial respiration and oxidative metabolism. In addition to hypoxia, 
decreased blood flow limits delivery of nutrients such as glucose and removal of metabolic 
waste such as lactate. This cascade of events results in irreversible neurological damage 
and leads to high rates of disability and death; nearly half of the survivors never regain 
functional independence (Go et al. 2014).
Arctic ground squirrels (AGS), Urocitellus parryii, resist cerebral ischemia injury. 
AGS is an obligate hibernating species that expends up to several weeks at a time in a 
highly regulated and reversible state of prolonged torpor. During torpor, metabolic rate, 
core body temperature (Tb), heart rate, and blood flow fall to ischemic-like levels without 
any evidence of ischemic injury (Frerichs et al. 1994, Ma et al. 2005, Weltzin et al. 2006). 
Previous work provides strong evidence that following cerebral I/R caused by cardiac
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arrest or mimicked by in vitro preparations, AGS have the innate ability to tolerate 
cerebral ischemia/reperfusion (Christian et al. 2008, Ross et al. 2006, Dave et al. 2009). 
Ion homeostasis assessed by anoxic depolarization is delayed in AGS brain by 1.23 min 
compared to rat brain (Dave et al. 2009). Nonetheless, AGS hippocampus resists up to 
2 h of oxygen glucose deprivation (OGD) (Christian et al. 2008), despite anoxic 
depolarization that occurs within ~ 6.6 min after onset of OGD (Dave et al. 2009).
Cerebral I/R initiates a cascade of events that causes excitatory release of 
glutamate leading to detrimental effects (Benveniste et al. 1984). However, it remains 
unclear, if glutamate is released in AGS after anoxic depolarization. Moreover, the 
contribution of hibernating season or state to ischemia tolerance in mammalian 
hibernators remains a matter of debate. Some studies suggest that the hibernation state 
increases tolerance to injury (Frerichs & Hallenbeck 1998, Zhou et al. 2001), and others 
show that tolerance is lost or decreased in animals during the summer season (Kurtz et 
al. 2006, Lindell et al. 2005). In contrast, other studies suggest that tolerance to modeled 
ischemia persists outside of the hibernation season (Dave et al. 2006, Ross et al. 2006, 
Christian et al. 2008).
In view of these observations, one goal of this study was to assess the influence 
of hibernating state (i.e., hibernating or not hibernating) and hibernation season (i.e., 
winter vs. summer) on resistance to OGD in AGS brain tissue. A second goal was to 
identify if events such as depletion of ATP, acidosis, and glutamate efflux that are 
associated with anoxic depolarization are attenuated in AGS. Here, we tested the 
hypothesis that tolerance to I/R injury modeled in an acute hippocampal slice preparation 
in AGS is independent of the hibernation season and persists even after glutamate efflux.
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In this study, we specifically focused on acute hippocampal slices because prior results 
show that hippocampus plays an important role in both memory and learning and is more 
vulnerable to ischemic insults than other regions of the brain (Ouyang et al. 2007, Erfani 
et al. 2015).
Our results show that at the tissue level when tissue temperature is maintained at 
36°C, hibernation season or state has no influence on OGD-induced cell death in AGS. 
Moreover, AGS tolerate OGD better than ischemic-susceptible Sprague-Dawley rats 
despite loss of ATP, excitatory amino acid release, and acidosis. In addition, tolerance 
persists under conditions that mimic acidosis and ischemic shifts characteristic of cerebral 
I/R in vivo.
3.3 Methods
3.3.1 Animal groups and determination of hibernation status
Arctic ground squirrel (AGS, Urocitellus parryii) and Sprague-Dawley rats were 
used for these experiments. All procedures were performed in accordance with University 
of Alaska Fairbanks Institutional Animal Care and use Committee (IACUC) and performed 
in accordance with the guidelines of the eighth edition of the Guide for the Care and Use 
of Laboratory Animals published by the US National Institutes of Health. Research was 
conducted in accordance with ARRIVE guidelines for reporting animal research (Kilkenny 
et al. 2010). AGS resist brain damage caused by global cerebral ischemia in vivo (Dave 
et al. 2009, Dave et al. 2006). The degree of ischemia resistance demonstrated by AGS 
is greater than other models of tolerance such as ischemia pre-conditioning. Moreover, 
unlike short-lived ischemia pre-conditioning that can be demonstrated in most species, 
ischemia resistance in AGS is chronic. Thus, AGS offer a unique and robust model of
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resistance to ischemia that is unparalleled by any other species and cannot be mimicked 
by other known manipulations. AGS of both sexes were trapped during mid-July in the 
northern foothills of the Brooks Range, Alaska, 40 miles south of the Toolik Field Station 
of the University of Alaska Fairbanks (68°38 N, 149°38 W; elevation 809 m) and were 
transported to Fairbanks, AK under permit obtained from The Alaska Department of Fish 
and Game. AGS were housed individually in facilities with an ambient temperature (Ta) 
of 16-18°C and a 12:12-h light-dark cycle and fed rodent chow, sunflower seeds, and 
fresh carrots and apples ad libitum  until mid-September, when they were moved to a cold 
chamber set to a Ta of 2°C and a 4: 20-h light-dark cycle. Male Sprague-Dawley rats (3­
4 months of age at the time of the experiment) were purchased from Simonsen 
Laboratories (Gilroy, CA, USA) and were transported by air to the University of Alaska 
Fairbanks. Rats were housed in groups of two to four at 20-21°C, with a 12:12-h light- 
dark cycle, and were fed rodent chow ad libitum .
The arctic ground squirrels hibernate only in the winter season; so, hibernating and 
interbout arousal groups are from the winter season. Tissue from summer AGS was 
collected during the summer season. Differences between summer AGS and all other 
AGS were assessed to determine if season influenced tolerance to cerebral I/R injury. 
AGS late in a torpor bout were collected after 80-90% of the duration of the previous 
torpor bout (8-12 days) and were defined as hibernating AGS (hAGS); AGS early after 
inducing arousal from torpor (4 and 20 h) were used as interbout euthermy AGS 
(ibeAGS). Post-reproductive summer euthermic animals sampled in July and August 2­
3 months after ending hibernation were used as summer euthermic AGS (seAGS). 
Subjects were matched as best as possible given the animals that were available for
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study. Detailed characteristics are provided in Table S3.1. Trectal and Ttemporalis were 
recorded at time of tissue collection. Arousal was induced by handling hibernating AGS. 
During interbout euthermy, tissue was collected 4 h after inducing arousal (4 h ibeAGS) 
or 20 h after inducing arousal (20 h ibeAGS). Ambient temperature and light-dark cycle 
remained the same for all groups.
3.3.2 Acute hippocampal slice preparation and in vitro modeled ischemia / reperfusion
Animals were anesthetized using 5% (v/v) isoflurane with medical grade O2 at a 
constant flow rate of 1.5 L/min. Once unresponsive, the animals were killed via rapid 
decapitation and brains were removed within 2 min. The whole brain was then placed in 
ice chilled, oxygenated HEPES-buffered artificial cerebral spinal fluid (HEPES-aCSF) 
containing 120 mM NaCl, 20 mM NaHCOs, 6.68 mM HEPES acid, 3.3 mM HEPES 
sodium salt, 5.0 mM KCl, and 2.0 mM MgSO4 (pH 7.3-7.4) to attenuate edema during 
the course of slicing and incubation. Rapidly dissected hippocampi were embedded in 
2.5% agar and transverse hippocampal slices. Approximately, 10 mm were discarded 
from both ends and 400 ^m thick slices from each hippocampus (~50-60 slices) were cut 
at approximately 2°C in oxygenated HEPES-aCSF using a Vibratome®1000 plus 
sectioning system (The Vibratome Company, St. Louis, MO, USA). The slices were then 
transferred to a brain slice keeper (Scientific Systems Design Inc., Mississauga, Ontario, 
CA, USA) and allowed to recover for 1-1.5 h at room temperature 20-21°C in HEPES- 
aCSF bubbled continuously with 95% O2/5% CO2 before transferring to microperfusion 
chambers.
To address the time course of injury, treatment was applied using 
an in vitro microperfusion technique described previously. Briefly, after 1 -1.5 h recovery
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as described above, individual slices were transferred gently to microperfusion chambers 
and lids sealed. The 4-8 parallel chambers were perfused with artificial cerebrospinal 
fluid (aCSF), pH 7.3 containing 120 mM NaCl, 45 mM NaHCO3, 10 mM glucose, 3.3 mM 
KCl, 1.2 mM NaH2PO4, 2.4 mM MgSO4, and 1.8 mM CaCl2 equilibrated with 95% O2/5% 
CO2 and submerged in aCSF bath at 36°C (± 0.2°C) at a flow rate of 7 ^L/min. The 
osmolarity of these solutions was between 290 and 300 mOsm. Sampling began no 
sooner than 75 min after submerging the sealed chambers to allow adequate time for 
stabilization of neurochemical efflux. Perfusates was collected at 15 min intervals and 
analyzed as indicated.
3.3.3 Treatment and injury conditions
To model in vivo ischemia/reperfusion (I/R)-induced alterations in the ionic 
microenvironment, hippocampus slices were perfused with one of the following: (i) aCSF, 
pH 7.3 as a control solution, (ii) OGD, pH 7.3 (glucose-oxygen-free aCSF), (iii) aCSF, pH
6.4, (iv) ionic shift solution (ISS), pH 6.5. aCSF, pH 6.4 containing 120 mM NaCl, 7.03 mM 
NaHCO3, 10 mM glucose, 3.3 mM KCl, 1.2 mM NaH2PO4, 2.4 mM MgSO4, and 1.8 mM 
CaCl2. Ionic shift solution (ISS), pH 6.5 contained 36.5 mM NaCl, 11 mM Na-gluconate, 
65 mM K-gluconate, 38 mM NMDG-Cl, 1 mM NaH2PO4, 0.13 mM CaCl2, 2.4 mM MgCl2, 
and 1 mM NaHCO3 as described previously (Ming et al. 2006). All aCSF solutions (pH 7.3 
and 6.4) were equilibrated with 95% O2 and 5% CO2, whereas the OGD and ISS solutions 
were equilibrated with 5% CO2 and 95% N2, for a minimum of 1 h until pH stabilized in 
the desired range. The PO2 in OGD and ISS solution varied from 0 to 2.9 mmHg with an 
average of six determinations of 1.1 mmHg as measured using a miniature Clark-style 
electrode (Instech Laboratories, Plymouth Meeting, PA, USA). Fractions were analyzed
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for cellular injury (LDH release) on the day of collection. Remaining volume was kept at 
-80°C for subsequent analysis.
3.3.4 Quantification of cell death
Lactate dehydrogenase (LDH) concentration in the perfusates was used as a 
marker of necrotic tissue damage. Perfusates, 50 ^L was transferred to 384-well plates 
and mixed with 50 ^L reaction solution provided in the LDH assay kit (Cayman Chemical, 
Ann Arbor, MI, USA). Optical density was measured at 490 nm 60 min later, using a 
microplate reader (BioTek Epoch, Winooski, VT, USA). Background absorbance at 
620 nm was subtracted. The LDH release was expressed in arbitrary units per mg of 
protein (Biorad protein assay kit, Hercules, CA, USA). The maximal releasable LDH was 
also obtained by treating the slices with 1% NP-40 lysis buffer (50 mM Tris-HCl, 0.5% 
sodium deoxycholate, 0.1% sodium dodecyl sulfate, 1% Igepal, 150 mM NaCl, 0.05% 
Triton X-100) at the end of each experiment.
3.3.5 Determination of ATP
ATP was determined after bath application of OGD or aCSF as described 
previously (Christian et al. 2008). In brief, slices were incubated in either aCSF or OGD 
solution and collected at the time point indicated. From each treatment condition, three 
hippocampal slices were transferred to a flat-bottomed microfuge tube containing 200 ^L 
of ice-cold 5% trichloroacetic acid, and were sonicated (8 pulses), centrifuged at 16 000 g 
for 1 min at 4°C. Supernatant was then collected and assayed for ATP using ENLITEN 
ATP assay (Promega, Madison, WI, USA). The pellets were further reconstituted with 
200 ^L 1 M NaOH and protein concentration was analyzed (Bio-Rad protein assay kit,
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Hercules, CA, USA). ATP activity was represented as a concentration of ATP normalized 
to total protein.
3.3.6 Capillary electrophoresis determination of glutamate and aspartate efflux
Glutamate and aspartate were analyzed by capillary electrophoresis. Perfusates 
were derivatized as described previously (Kirschner et al. 2009, Kirschner et al. 2007) to 
form highly fluorescent cyanobenz[f]isoindole amino acids (CBI-amino acids). Briefly, 
2 qL of thawed perfusates was reacted with 2 qL of 2 mM naphthalene-2,3- 
dicarboxaldehyde in methanol and 2 qL NaCN (5.5 mM) in 60 mM sodium tetraborate. 
Cyanide solution contained 3 qM D-amino adipic acid as internal standard. Samples were 
reacted at 20-21 °C for approximately 20 min prior to analysis. CE-LIF was performed on 
a custom in-house-built instrument using a 420-nm diode laser, 490-nm bandpass filter, 
and photomultiplier tube (PMT) for LIF detection. Samples were injected onto a bare 
fused silica capillary of dimensions 25 cm * 25 qm (22.5 cm to detection window) for 1­
3 s at 380-mbar vacuum and separated using positive polarity (20 kV). Separation buffer 
optimized for analysis of L-glutamate and L-aspartate is a 50-mM sodium tetraborate 
background electrolyte adjusted to pH 9.3. Background electrolyte additionally contained 
1.0 mM p-cyclodextrin to decrease sample run time for glutamate and aspartate analysis. 
The addition of p-cyclodextrin allowed for baseline resolution of glutamate, aspartate, and 
the internal standard in < 2 min. PeakFit software (SeaSolve Software Inc., Framingham, 
MA, USA) was used to process raw data and quantify peak areas in all experiments based 
on a Gaussian peak shape for each analyte. Linear calibration curves were constructed 
for glutamate and aspartate as a function of concentration versus the peak area ratio 
(analyte area/internal standard area). Efflux of analytes was quantified as a concentration
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of glutamate or aspartate normalized to total protein for the slice used in the efflux 
experiment and represented as a fraction of baseline glutamate or aspartate release.
3.3.7 Statistical analysis
A priori power analysis (G*Power software, (Faul et al. 2007)) was performed to 
estimate sample size needed to yield 80% power for detecting a significant (p < 0.05) 
effect of treatment. An expected difference in means of 17.81 and standard deviations of 
10.93 and 2.24, taken from rat OGD and seAGS OGD indicates that a sample size of five 
slices will have 80% power for detecting a difference. For experimental group with smaller 
sample size, no non-significant effect was under powered. No animal was excluded from 
the study. Slices from animals were randomly assigned to treatment and control groups 
without prior knowledge to the treatment conditions. The statistical analysis was 
performed on the data that were normalized to baseline and expressed as fraction of 
baseline to avoid any variation in the baseline values among the treatment groups. 
Baseline was calculated as the mean of the two samples preceding onset of treatment 
(Table S3.2). Data processing and statistical analyses were performed using Microsoft 
Office Excel 2010 and Prism6 (GraphPad, San Diego CA, USA). Data were analyzed with 
one-way or two-way anova with repeated measures. Significant main effects or 
interactions were followed by t-tests with Bonferroni's correction. Data are expressed as 
mean ± SEM, and p < 0.05 was considered statistically significant. Treatment with aCSF 
and OGD were run in every experiment and combined for the final analysis; as a result, 
sample size was larger in aCSF and OGD groups than in many of the experimental 
manipulations.
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3.4 Results
3.4.1 Tolerance to OGD injury in AGS hippocampus is not dependent on hibernation 
season
To investigate whether at the tissue level when tissue temperature is normalized 
to 36°C, AGS are more tolerant to OGD injury than ischemic-susceptible rats; 
hippocampal slices from a cohort of each species were examined. Following 30 min of 
OGD, slices harvested from rats displayed a significant increase in LDH release relative 
to control slices (aCSF, n = 25 slices; OGD, n = 30 slices, 15 animals, p < 0.0001, two­
way anova, treatment * time). seAGS showed a significant increase in LDH release 
relative to aCSF treated control slices (aCSF, n = 28 slices; OGD, n = 30 slices, 14 
animals, p = 0.0001, two-way anova, treatment * time). When OGD treated slices from 
rats and seAGS were compared, rat slices displayed a significantly greater degree of LDH 
efflux than AGS slices (rat, OGD, n = 30 from 15 animals; AGS, OGD, n = 30 from 14 
animals, p < 0.0001, two-way anova, species * time) (Figure. 3.1a).
Next, to confirm our ability to detect an increase in LDH release in AGS 
hippocampus, we applied TritonX-100, a non-ionic detergent to directly disrupt cell 
membrane as a positive control. Treatment of slices with 0.1% TritonX-100 produced a 
significant increase in LDH release (aCSF, n = 4 slices; 0.1% TritonX-100, n = 4 slices, 
two animals, p < 0.0001, two-way anova, treatment * time) (Figure. 3.1b). We further 
analyzed the total LDH content per slice to investigate if the amount of LDH release 
following OGD is limited by total LDH content. No difference in total LDH content was 
observed in slices from rats or AGS that were subjected to either aCSF or OGD treatment 
(Figure S3.1). These results suggested that the difference in LDH release between rats
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and AGS is not because of a difference in total LDH content but is because of a difference 
in the injury associated with OGD exposure.
Next, to address if tolerance to OGD injury depends on the hibernation season, 
groups of AGS -  seAGS, hAGS, and ibeAGS, 4 or 20 h after inducing arousal, were 
matched as best as possible for season, frequency, age, sex, and body weight prior to 
tissue collection. Body weight of seAGS was greater than hAGS and ibeAGS because of 
the seasonal fattening of this species (Sheriff et al. 2013). Because date of birth is not 
known for AGS, age is only reported as adult which means > 1 year old. Trectal and 
Ttemporalis did not differ between seAGS and ibeAGS, 4 h or 20 h after inducing arousal, 
but were as expected warmer than Trectal and Ttemporalis in hAGS at time of tissue collection 
(Table S3.1). All tissues were normalized to 36°C prior to experimental manipulations. 
Results show that OGD induced a significant increase in total LDH release in the 
20 h ibeAGS group compared to seAGS (p = 0.01, one-way anova, n = 30-33 slices, 
(Figure 3.1c). Relative to aCSF (Figure 3.1c and d), OGD induced a onefold increase in 
total LDH release in seAGS, 4 h ibeAGS, and hAGS slices. In contrast, OGD induced a 
threefold increase in LDH release in 20 h ibeAGS. The same pattern was seen when the 
effect of OGD on LDH was assessed over time. A significant LDH response was observed 
in slices from 20 h ibeAGS during OGD compared to seAGS, 4 h ibeAGS, and hAGS 
slices (p < 0.0001, two-way anova season x time). However, the statistically significant 
injury observed in slices taken from 20 h ibeAGS OGD, was less than the injury observed 
in slices from rat OGD (p < 0.0001, two-way anova species (rat and 20 h ibeAGS) * time) 
(Figure 3.1a and c). These results suggest that 20 h into interbout euthermy, AGS 
hippocampus is the most vulnerable to OGD relative to other times in the hibernation
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season. However, even at this most vulnerable time point, AGS are still less vulnerable 
to OGD-induced cell death than rats.
3.4.2 Tolerance to injury in AGS hippocampus is not reversed by ionic shift solution (ISS) 
or low pH
Ionic homeostasis has been tightly linked to cell injury/death (Bortner & Cidlowski 
2004). To simulate the ionic microenvironment in our in vitro slice preparation to mimic 
the changes in the extracellular milieu that occurs in vivo during cerebral I/R, slices from 
rats and AGS were subjected to 30 min of an ionic shift solution insult (K+ = 65 mM; 
Na+ = 55 mM; HCO3- = 2.5 mM, Cl- = 77.0 mM, pH 6.5) and LDH release was measured. 
Results show that slices from rats show significant release of LDH as compared to control 
slices (aCSF, n = 3; ISS, n = 3 slices from four animals, p < 0.0001, two-way anova, 
treatment x time). In contrast, ISS had no influence on slices from seAGS (aCSF, n = 3; 
ISS, n = 3 from three animals, p = 0.10, two-way anova, treatment * time). ISS-treated 
slices from rats also displayed significant increase in LDH release compared to seAGS 
slices. (p < 0.0001, two-way anova, species * time) (Figure 3.2a). Next, we addressed 
the role of pH alone in acute hippocampal slices. Rat slices subjected to 30 min low pH
6.3 causes significant LDH release (aCSF, pH 7.4 = 7 slices, six animals; aCSF, pH
6.3 = 7 slices, five animals, p = 0.001, two-way anova, treatment * time). In contrast, 
AGS slices displayed no significant release of LDH with low pH compared to control slices 
(aCSF, pH 7.4 = 7 slices, five animals; aCSF, pH 6.3 = 7 slices, four animals). When low 
pH-treated slices from rats and seAGS were compared, rat slices displayed significantly 
greater LDH efflux than AGS slices (rat aCSF pH 6.3, n = 7 slices, five animals; AGS
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aCSF pH 6.3, n = 7 slices, four animals, p < 0.0001, two-way anova, species * time) 
(Figure 3.2b).
We also explored pH-dependent injury over a wider range of pH (pH 7.4, 7.0, 6.6,
6.3) in seAGS. We found that pH did not influence LDH release in seAGS (aCSF pH
7.4, n = 7; aCSF pH 7.0, n = 4; aCSF pH 6.6, n = 5; aCSF pH 6.3, n = 7; 15 
animals; p = 0.33, one-way anova) (Figure S3.2). This suggests that AGS hippocampus 
is less vulnerable to the damaging effects of ISS or low pH than rats.
3.4.3 AGS hippocampus resists OGD injury not because of enhanced energy 
conservation
In the context of bioenergetics, the brain consumes large amounts of oxygen to 
maintain ionic gradients across neuronal plasma membranes. However, ischemic injury 
causes bioenergetic failure leading to depletion in cellular ATP and prevents neurons from 
maintaining membrane potential, resulting in neuronal depolarization. Here, we 
investigated whether resistance to ischemic injury in AGS is as a result of preservation of 
energy homeostasis. We tested this by exposing acute hippocampal slices from seAGS 
and rats to 30 min of OGD and monitoring ATP levels. Results show that exposure of rat 
hippocampal slices to 30 min OGD produced a significant depletion in ATP when 
compared to control slices. Slices with OGD showed no significant signs of ATP 
restoration even after 3 h of reperfusion (aCSF, n = 4 slices; OGD, n = 4, four 
animals, p = 0.0037, two-way anova, treatment x time; Figure 3.3a. Hippocampal slices 
from seAGS displayed similar depletion in ATP following OGD when compared to slices 
exposed to aCSF (aCSF, n = 3 slices, OGD, n = 3 slices, three animals, p = 0.0097, two­
way anova, treatment * time). Tendency to restore ATP following reperfusion was similar
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in rat and AGS slices Figure 3.3b. These results indicate that energy homeostasis is 
disrupted in AGS in a fashion similar to rats and that tolerance to OGD cannot be 
explained by enhanced energy homeostasis.
3.4.4 Tolerance to OGD in AGS hippocampus is not because of inhibition of excitatory 
neurotransmitter efflux
We next investigated if tolerance to ischemia in AGS is associated with dampening 
of excitatory neurotransmitter release, which occurs following ischemia-induced depletion 
of cellular ATP. This was tested by exposing acute hippocampal slices from seAGS and 
rats to 30 min of OGD and monitoring efflux of glutamate and aspartate using capillary 
electrophoresis. Results show that rat slices exposed to OGD displayed a 2.3-fold 
increase in glutamate efflux over basal efflux (n = 16 control slices, 12 animals; n = 17 
OGD slices; 12 animals, p < 0.0001, two-way anova, treatment * time) Figure 3.4a; 
aspartate efflux also increased during OGD in rats (1.7-fold increase over basal 
efflux, n = 16 control slices, 12 animals; n = 17 OGD slices; 12 animals, p < 0.0001, two­
way anova, treatment * time) Figure 3.4c. After the onset of reperfusion, the glutamate 
levels returned to baseline levels within 60 min, aspartate returned to baseline levels 
within 45 min. seAGS slices exposed to 30 min OGD displayed both glutamate (threefold 
increase over basal level, p < 0.0001, two-way anova, treatment x time) and aspartate 
efflux (1.3-fold increase over basal level, p < 0.0001, two-way anova, 
treatment * time; n = 14 slices from five seAGS) (Figure 3.4b and d). The magnitude and 
time course of excitatory amino acid efflux in AGS approximates efflux seen in rat 
hippocampal slices. Despite excitatory neurotransmitter efflux, AGS resist OGD-induced
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injury suggesting that cerebral I/R injury is modulated in AGS downstream to, or 
independent of glutamate or aspartate release.
3.5 Discussion
Using an in vitro microperfusion approach to avoid the influence of cold tissue 
temperature that is unavoidable in whole animal studies, we have identified that the 
hibernating state or the hibernation season is not necessary for AGS tolerance to cerebral 
I/R modeled in acute hippocampal slices. The time that AGS are most vulnerable to OGD 
is 20 h into an interbout arousal although even at this most vulnerable period, resistance 
to OGD in AGS is substantially better than resistance to OGD in rat hippocampal slices. 
Secondly, our data unequivocally show that tolerance to OGD in AGS hippocampal slices 
occurs despite loss of ATP, and excitatory amino acid release and persists during 
conditions that mimic acidosis (Siesjo 1988) and ionic shifts characteristic of cerebral I/R 
(Hansen & Zeuthen 1981, Yanagihara & McCall 1982).
3.5.1 The hibernating state or the hibernation season is not necessary for AGS tolerance
This work showing that in AGS, the hibernation season or state does not define 
tolerance to OGD is significant because it is the first set of studies to systematically test 
the response to OGD in hippocampal tissue throughout the season and hibernation state 
in AGS. Dave et al., concluded that in AGS, hibernation season was not required for 
resistance to brain injury following cardiac arrest (Dave et al. 2006), however, studies 
were only performed during the summer season. (Christian et al. 2008) concluded that 
hippocampal slices from AGS were least vulnerable to OGD during the summer season. 
However, the propidium iodide staining used by (Christian et al. 2008) to measure cell 
death produced high background levels. Background levels of cell death were highest in
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the summer season and could have masked effects of OGD. (Ross et al. 2006) also 
showed that the hibernation state did not influence tolerance to OGD in the first 24 h of 
culture. However, as with (Christian et al. 2008) , high background cell death measured 
in cultured slices using propidium iodide may have compromised sensitivity to detect cell 
death. These results confirm that when tissue temperature is normalized to 36°C both 
summer and hibernating AGS resist OGD. While vulnerability to OGD is always less in 
AGS than in rats, vulnerability in AGS does increase slightly toward the end of arousal. 
Arousal from prolonged torpor is the most stressful aspect of hibernation indicated by 
increased levels of Hypoxia-inducible factor 1-a (HIF-1a) and inducible nitric oxide 
synthase (Ma et al. 2005). It is likely that the physiological challenge of rewarming, 
reanimating, and reperfusing the brain contributes to vulnerability to OGD.
Tolerance, independent of season or state may be unique to the AGS. Others 
(Frerichs & Hallenbeck 1998) showed that hibernation state increases tolerance to OGD 
in 13-lined ground squirrel hippocampus. (Kurtz et al. 2006) demonstrated that 
hibernation season increases tolerance to I/R in 13-lined ground squirrel in liver and gut. 
In contrast, the hibernation season is not required for tolerance to I/R in other organs in 
AGS (Bogren et al. 2014a, Bogren et al. 2014b). A recent study in AGS, however, did 
reveal cardioprotective benefit of the hibernation season during cardiopulmonary 
bypass in vivo with a core body temperature of 18°C (Quinones et al. 2016). Heart may 
differ from brain and a longer duration (45 min) of ischemia studied in the 
cardiopulmonary bypass procedure may have revealed a seasonal difference not evident 
in studies of cerebral I/R tolerance in AGS.
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Cold tissue temperature is protective (Busto et al. 1987) and confounds whole 
animal comparisons between hibernating and euthermic ground squirrels. With the acute 
slice model, it is possible to avoid the influence of cold tissue temperature which is not 
possible in whole animal models because hibernating animals have a core and brain 
temperature near 0°C and euthermic animals have a core and brain temperature near 
37°C. Seasonal comparisons between summer and winter euthermic animals can be 
made in whole animals without confounding influence of temperature since both groups 
have body temperatures near 37°C. Our results are consistent with whole animal studies 
that show that tolerance to I/R or hypoxia does not require the hibernation season 
(D'Alecy et al. 1990, Dave et al. 2009, Dave et al. 2006, Bogren et al. 2014a, Bogren et 
al. 2014b). The present results confirm that AGS do not need to be cold to tolerate 
cerebral I/R better than rats although cold tissue temperature would likely enhance 
tolerance as noted by (Frerichs & Hallenbeck 1998).
Our results suggest that the contribution of A1 receptors to seasonal hibernation 
does not impact cerebral I/R tolerance since season did not play a significant role in 
tolerance. A1 receptor activation is necessary and sufficient to drive onset of hibernation, 
however, only in the winter season (Jinka et al. 2011). Sensitivity to A1 adenosine 
receptor agonists increase in the hibernation season (Olson et al. 2013) and A1 
adenosine receptor agonists are neuroprotective (Cunha 2005). However, differences in 
A1 sensitivity between summer and winter is not relevant to cerebral I/R tolerance since 
we and others have not found a significant influence of season on tolerance. Indeed, 
tolerance in AGS does not depend on the hibernation state or season.
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The novel microperfusion method developed in our laboratory (Kirschner et al. 
2009) for study of cell death in acute, adult slices overcomes the limitations of methods 
used in prior studies where high baseline cell death may have compromised 
interpretation. The microperfusion approach minimizes background cell death by 
capturing LDH release from the entire slice. This approach is an improvement over other 
methods where stains such as propidium iodide show cell death only on the surface of 
the freshly cut slice (Ross et al. 2006, Christian et al. 2008). Moreover, the microperfusion 
approach allows us to study cell death in adult AGS tissue. The ability to study adult tissue 
is an advantage since access to perinatal tissue is restricted by the seasonal breeding 
cycle of AGS. In addition, interpretation of organotypic cultures is limited by 
developmental age of the tissue (Fukuda et al. 1995). The in vitro microperfusion 
approach in our study might not apply to the in vivo scenario wherein whole animal 
mechanisms such as pH buffering capacity and limited inflammatory response contribute 
to tolerance to ischemia reperfusion injury (Bogren et al. 2014a, Bogren et al. 2014b). 
Nonetheless, the microperfusion approach isolates processes occurring at the tissue level 
so that interpretation is not confounded by whole animal physiology. Moreover, the 
microperfusion approach allows for the concentration of each component in the perfusion 
fluid to be defined and manipulated and cell death quantified in a time-dependent manner. 
In this way, pH can be decreased without hypoxia and cell death monitored with temporal 
resolution relevant to onset and recovery from low pH. Such discrete manipulation of 
individual components of the extracellular milieu is not possible in vivo where, for 
example, pH decreases following anoxia. Thus, the microperfusion approach gives 
superior control over the extracellular environment that could not be achieved in vivo. We
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acknowledge that the slice preparation differs from the in vivo scenario (Cho et al. 2007, 
Saeidnia et al. 2015) and in this way serves our objective to study processes at the tissue 
level that do not depend on cold tissue temperatures and confer tolerance to AGS.
LDH release was used to interpret cell death in our study. LDH release is a 
standard approach to monitor cell death (Chan et al. 2013) which is released from the 
cytosol because of membrane disruption and not because of metabolic changes related 
to OGD. This approach of monitoring cell death overcomes the limitations of methods 
used in prior studies where high baseline cell death because of acute damage at the slice 
surface challenged interpretation (Ross et al. 2006, Christian et al. 2008). The 
microperfusion approach minimizes background cell death by capturing LDH release from 
the entire slice. This approach overcomes problems with propidium iodide staining. Like 
LDH release, propidium iodide staining depicts increased membrane permeability; 
however, propidium iodide shows cell death only on the surface of the freshly cut slice.
3.5.2 AGS hippocampus resists OGD as well as ischemic shift solution better than rat
Traditionally, OGD is used to model in vivo ischemic insult, however, due to 
dilution OGD excludes other deleterious aspects of the ischemic milieu (Yao et al. 2007a, 
Lo 2008). This artifact of the in vitro preparation could not explain tolerance to OGD 
because resistance to modeled ischemia was observed in AGS even when the perfusion 
fluid was modified to mimic loss of ion homeostasis and subsequent changes in the 
extracellular fluid that occurs in vivo. AGS were not vulnerable to ischemic shift solution 
(ISS) or to acidic media (~pH 6.4). ISS includes ionic alterations sufficient to induce 
spreading depression in cortex (Zhou et al. 2001). ISS also mimics tissue acidosis 
sufficient to activate acid sensing ion channels which increase calcium permeability and
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leads to cell death during cerebral I/R (Xiong (Xiong et al. 2004). Previous studies have 
shown that painted turtle neurons also tolerate prolonged ischemic solution treatment 
(Pamenter et al. 2012).
3.5.3 AGS hippocampus tolerates OGD despite ATP depletion
Resistance to OGD is evident in AGS although there is a depletion in ATP, a 
hallmark of ischemic injury (Sato et al. 1984). In contrast, a balance between ATP demand 
and ATP supply prevails in other anoxia-tolerant species such as the painted turtle via a 
coordinated reduction in ATP demand in the absence of oxygen (Bickler & Buck 2007). 
In AGS, tolerance to OGD resides despite ATP depletion and is not a result of restoration 
of ATP. This finding distinguishes AGS from anoxia-tolerant turtle where ATP recovers 
slowly over time (Pamenter et al. 2012). Depletion of ATP is also seen during OGD in 
hippocampal slices taken from hibernating AGS although the initial loss of ATP is delayed 
relative to AGS during interbout arousal (Christian et al. 2008). Here, we focused 
exclusively on seAGS since we found no difference in tolerance to OGD between winter 
hibernating and summer active AGS. Anoxia depletes ATP similarly in hippocampal slices 
from naked mole rats and mice (Larson et al. 2012).
3.5.4 AGS hippocampus tolerates OGD injury even after ischemic depolarization- 
associated excitatory glutamate efflux
This study also revealed that resistance to OGD in AGS hippocampus is not 
because of attenuation in excitatory amino acid efflux such as glutamate and aspartate. 
Ischemia-induced depolarization is delayed in AGS relative to rats in vitro and in vivo. 
Nonetheless, depolarization is observed within 7 min in acute slices and 3 min during 
cardiac arrest in vivo (Dave et al. 2009). The 30 min of OGD applied in this study should
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have been sufficient to depolarize hippocampal neurons and indeed led to an increase in 
glutamate and aspartate efflux that was similar to rats and occurred with a time course 
consistent with in vivo studies (Benveniste et al. 1984, Hagberg et al. 1985, Mitani et al. 
1994). While delayed depolarization may contribute to tolerance, additional protective 
mechanisms are most likely unrelated to glutamate release. Our result is in contrast to 
anoxia-tolerant species such as fresh-water turtle and crucian carp that show a decrease 
in tissue level of excitatory neurotransmitter glutamate and aspartate (Nilsson 1990); 
Down-regulation of glutamate release is suggested to be modulated by synergistic activity 
of K (ATP) (+) channels, adenosine and GABA(A) receptors (Milton et al. 2002, 
Thompson et al. 2007). Our result suggests that tolerance to OGD in AGS is not because 
of inhibition of excitatory neurotransmitter release.
3.6 Conclusion
In agreement with previous results (Dave et al. 2006, Ross et al. 2006, Christian 
et al. 2008), this study shows that hippocampal slices from AGS are unique in lack of 
seasonal dependence associated with tolerance to OGD in vitro and cardiac arrest in 
vivo. Here, we show that although AGS, 20 h into an interbout arousal are vulnerable to 
OGD, the level of susceptibility is negligible when compared to rats. We also conclude 
that at the tissue level when tissue temperature is normalized to 36°C despite ATP 
depletion, ionic derangement, tissue acidosis, and excitatory neurotransmitter efflux, AGS 
hippocampus resists OGD injury. Unlike hypoxia- and anoxia-tolerant species where 
tolerance is linked to ATP restoration and neurotransmitter release, AGS may have 
evolved unique adaptations to physiological extremes and subsequently cerebral I/R.
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Figure 3.1: AGS brain tolerates OGD better than rat regardless of hibernation state or
season.
(a) LDH in perfusates collected every 15min increases in rat hippocampal slices exposed 
to OGD (rat, OGD), but not in rat slices exposed to aCSF (rat, aCSF), nor in slices 
harvested from summer euthermic AGS and exposed to aCSF (seAGS, aCSF). A small 
amount of LDH is released from slices collected from seAGS and exposed to OGD 
(seAGS, OGD). *p < 0.05 rat aCSF vs. rat OGD, +p < 0.05 rat OGD vs. seAGS 
OGD, #p < 0.05 seAGS aCSF vs. seAGS OGD. (b) Exposing seAGS slices to TritonX 
increases LDH release (*p < 0.05 0.1% TritonX versus aCSF). (c) AGS hippocampal 
slices are most vulnerable to OGD when collected from AGS 20 h into an interbout arousal 
(20 h ibeAGS). Insert shows the sum of LDH in perfusates collected between 15 and 210 
min from slices harvested from (1) seAGS, (2) AGS 4h into an interbout arousal 
(4h ibeAGS), (3) AGS 20h into an interbout arousal (20 h ibeAGS), or from (4) hibernating 
AGS (hAGS); *p < 0.05 seAGS vs 20h ibeAGS, +p < 0.05 4h ibeAGS versus 
20h ibeAGS, #p < 0.05 hAGS versus 20h ibeAGS. (d) Exposure of slices from the same 
groups of animals as in (c) to aCSF has no effect on LDH release. Gray bar indicates 
30min treatment period. Data shown are means ± SEM.
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Figure 3.2: AGS brain is tolerant to ionic shift solution (ISS) or low pH injury.
(a) Shows time course of LDH release in acute hippocampal slices from rat and seAGS 
exposed to ISS, pH 6.3 or aCSF, pH 7.3. *p < 0.05 rat aCSF versus rat ISS (pH
7.4), +p < 0.05 rat ISS versus seAGS ISS (pH 6.3). (b) Shows time course of LDH release 
in acute hippocampal slices from rat and seAGS exposed to low pH 6.3 or aCSF, pH 7.3. 
*p < 0.05 rat aCSF pH 7.4 versus rat aCSF pH 6.3, +p < 0.05 rat aCSF pH 6.3 
versus seAGS aCSF pH 6.3. Gray bar indicates treatment period. Means ± SEM.
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Figure 3.3: ATP declines in rat and seAGS following OGD.
Levels of whole tissue ATP were determined over time following bath application of 
treatment in slices from (a) rat (aCSF versus OGD) and (b) seAGS (aCSF versus OGD) 
subjected to either 30 min of aCSF or OGD followed by 3 h reperfusion. Gray bar 
indicates insult period. Data shown are means ± SEM, *p < 0.05 versus aCSF.
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Figure 3.4: Oxygen glucose deprivation (OGD) induces efflux of glutamate and aspartate 
in both seAGS and rats.
Time-dependent excitatory neurotransmitter (glutamate and aspartate) efflux in rat 
and seAGS hippocampal slices induced by 30 min OGD insult. (a) and (b) illustrates 
glutamate efflux, (c) and (d) illustrate aspartate efflux in rat and seAGS hippocampal 
slices during OGD insult (n = 17 slices from six rats, n = 14 slices from five seAGS). Gray 
bar indicates insult period. *p < 0.05 for OGD versus artificial cerebral spinal fluid (aCSF) 
group. Data shown are means ± SEM.
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Figure 3.5. Graphical abstract. AGS tolerate OGD injury despite glutamate efflux and 
acidosis
AGS hippocampal slices tolerate OGD injury independent of hibernation season (summer 
versus winter) and state (hibernating versus interbout arousal). AGS tolerate OGD (green 
arrow) better than ischemic susceptible Sprague-Dawley rat (red arrow) despite loss of 
ATP, glutamate release, and acidosis. These findings point towards as yet undefined 
mechanisms of tolerance at the tissue level that are unique to AGS.
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Supplementary Figure 3.1: Total LDH content from rat and AGS
Total LDH content per slice from rats (n = 15) and AGS (n = 34) subjected to 30 min of 
either aCSF or OGD treatment is not different. At the end of each experiment, slices were 
homogenized and total LDH content per slice was measured. Data shown are 
means ± SEM.
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Supplementary Figure 3.2: Total LDH release in AGS subjected to different pH exposure
Total LDH release per slice from seAGS subjected to a range of low pH insult (aCSF pH
7.4, n = 7; aCSF pH 7.0, n = 4; aCSF pH 6.6, n = 5; aCSF pH 6.3, n = 7; 15 animals) for 
30 min. Total LDH release per treatment was normalized to baseline LDH release per mg 
of protein (Baseline values for LDH in arbitrary units per mg protein: aCSF pH
7.4 = 0.218 ± 0.0668; aCSF pH 7.0 = 0.300 ± 0.0665; aCSF pH 6.6 = 0.240 ± 0.0686; 
aCSF pH 6.3 = 0.260 ± 0.0302). Data shown are means ± SEM.
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T ablel: Characteristics o f  study groups:
Physiological
Parameters
seAGS ibeAGS (20h) ibeAGS (4h) AAGS Rat
Age (days) Adult Adult Adult Adult 87.60±25.45
Sex
Male (n= 10) 
Female (n= 4)
Male (n= 8) 
Female (n= 5)
Male (n= 1) 
Female (n= 2)
Male (n= 4) 
Female (n= 0)
Male (n= 14) 
Female (n= 1)
Body Weight (g) 1037.6±247.3 616.9±160.3 585.4±224.3 619.5±132.7 354.3±50.5
1 recta l ( ° t  ) 36.7±1.4 36.1±0.8 36.6±0.6 4.5±1.2 36.6±0.9
Ttem poral!* (  ° (  ) 35.9±1.1 35.6±0.8 35.8±0.6 5.7±1.5 35.7±0,4
Supplementary Table 3. 1: Characteristics of study groups
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Treatment Group Baseline values for LDH 
absorbance (Arbitrary unit)
Figure 1
rat aCSF 0.139 ±0.015
rat OGD 0.189 ±0.020
.wAGS aCSF 0.204 ± 0.025
seAGS OGD 0.189 ±0.01
4h ibeAGS OGD 0.262 ±0.036
hAGS  OGD 0.124 ±0.010
20h the AGS OGD 0.208 ± 0.02 L
Figure 2 (A)
rats aCSF pH 7.4 0.183 ±0.017
rat ISS pH 6.5 0.099 ±0.019
seAGS, aCSF pH 7.4 0.213 ±0.056
seAGS ISS pH 6.5 0.126 ±0.003
Figure2 (13)
rat, aCSF pH 7.4 0 .109 ±0.0164
rat aCSF pH 6.3 0.209 ±0.0397
seAGS, aCSF pH 7.4 0.218 ±0.0668
seAGS ISS pH 6.5 0.126 ±0.003
seAGS aCSF pH 6.3 0.260 ±0.0302
Supplementary Table 3. 2: LDH release (baseline values) in treatment groups
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Chapter 4: Arctic Ground Squirrel resist peroxynitrite-mediated cell death in response to
oxygen glucose deprivation3
4.1 Abstract
Cerebral ischemia-reperfusion (I/R) injury initiates a complex cascade of events, 
which causes generation of nitric oxide (NO) and superoxide(O2"). NO and O2" rapidly 
combine to form peroxynitrite (ONOO-), a potent oxidant. Arctic ground squirrel (AGS; 
Urocitellus parryii) is a natural model of high tolerance to I/R injury, however, the 
mechanisms that contribute to tolerate this pathological scenario remains elusive. Here, 
we hypothesize that tolerance to I/R injury modeled in an acute hippocampal slice 
preparation in AGS is modulated by reduced oxidative and nitrative stress associated with 
oxygen-glucose deprivation (OGD).
Hippocampal slices (400 microns) from rat and AGS were subjected to OGD to 
mimic I/R in vivo using a novel microperfusion technique. Brain slices were exposed to 
NO, O2 - donors with and without OGD; pretreatment of slices with inhibitors of NO, O2 - 
and ONOO- followed by OGD. In control slices, treatment was administered by switching 
to standard aCSF. Perfusates were collected every 15 min and analyzed for LDH release, 
an indicator of cell death. Oxidative and nitrative damage was monitored using the 
markers: 3-nitrotyrosine (3NT) and 4-hydroxynonenal (4HNE).
Results show that 1) NO donor alone is not sufficient to cause cell death, but with 
OGD enhances the cell death more in rat than AGS; an inhibitor of nNOS attenuates OGD
3 Published as Bhowmick S, Drew KL. "Arctic ground squirrel resist peroxynitrite-mediated 
cell death in response to oxygen glucose deprivation.” Free Radic Biol Med. 2017 Sep 
28. doi: 10.1016/j.freeradbiomed.2017.09.024. [Epub ahead of print]. PubMed PMID: 
28962873
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induced injury in rat but has no effect in AGS. 2) O2 - donor alone causes injury in rat more 
than in AGS and the injury aggravates when combined with OGD; SOD mimetic 
attenuates OGD injury in rat, but no has effect in AGS. 3) ONOO- inhibitor attenuates 
OGD injury in rat but has no effect in AGS. Rat also shows a higher level of 3-nitrotyrosine 
(3NT) and 4-hydroxynonenal (4HNE) with OGD insult than AGS suggesting that greater 
level of injury is via formation of ONOO- during cerebral I/R injury.
4.2 Introduction
Cerebral ischemia-reperfusion (I/R) injury remains an important cause of mortality 
and chronic morbidity in patients suffering from stroke and cardiac arrest (Soler & Ruiz 
2010). Ischemic condition initiates a cascade of molecular events wherein ATP levels 
rapidly decline, arresting metabolic activity (Erecinska & Silver 2001). Since the 
maintenance of the membrane potential relies on ATP-dependent ion pumps, the cell 
membrane depolarizes. This causes an excess influx of calcium through voltage-gated 
calcium channels. As the sodium gradient dissipates, sodium-glutamate cotransporters 
release glutamate into the extracellular space (Rossi et al. 2000), which activates 
postsynaptic glutamate receptors, particularly N-methyl-D-aspartate (NMDA) channels. 
The activated NMDA channels are responsible for a significant part of the calcium (Ca2+) 
influx. Excessive intercellular Ca2+ overexcites cells and causes generation of harmful 
chemicals such as free radicals and reactive oxygen and nitrogen species (Uttara et al. 
2009).
A major event during cerebral ischemia is the generation of nitrogen and oxygen 
free radicals. These reactive species include superoxide (O2 -) and nitric oxide (NO) that 
has the great tendency to react with each other to form a potent oxidant peroxynitrite
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(ONOO-). In the brain, NO is formed by the NO synthase (NOS) isoforms, a family of 
enzymes (Guix et al. 2005, Calabrese et al. 2007). Under physiological conditions, NO 
is responsible for maintenance of basal cerebral blood flow (CBF) (Toda et al. 2009). 
However, during ischemia, cerebral NO rapidly increases to 2-4 |jM, producing damaging 
levels of NO (Murphy 1999, Kader et al. 1993). Concomitantly, a burst of free radicals 
such as O2~ (Cuzzocrea et al. 2001, El Kossi & Zakhary 2000, Tang et al. 2012, Suh et 
al. 2008) is produced after the ischemic event. This scenario is deleterious because O2 - 
anion has a high affinity for NO, higher than for the superoxide dismutase (Huie & 
Padmaja 1993, Cudd & Fridovich 1982). NO and O2~ react with each other in an 
equimolar stoichiometric ratio forming a potent oxidant, ONOO- further contributing to 
injury (Beckman et al. 1990, Reiter et al. 2000, Zielonka et al. 2010).
Studies have confirmed that some invertebrates and vertebrates exhibit tolerance 
to ischemic or hypoxic injury (Larson et al. 2012). Ischemia causes a decrease in cerebral 
blood flow which in part leads to tissue hypoxia (reduced O2). Low O2 causes a reduction 
in mitochondrial respiration and oxidative metabolism. In addition to hypoxia, decreased 
blood flow limits delivery of nutrients such as glucose and removal of metabolic waste 
such as lactate. Arctic ground squirrel (AGS), Urocitellus parryii, is an obligate 
hibernating species that tolerate cerebral I/R caused by cardiac arrest or mimicked by in 
vitro preparations (Dave et al. 2009, Ross et al. 2006, Christian et al. 2008). Resistance 
to brain injury does not depend on hibernation state and persists at warm tissue 
temperatures (Bhowmick et al. 2017b). Studies show that AGS hippocampus resists up 
to 2 hr of OGD (Christian et al. 2008), despite anoxic depolarization that occurs within ~
6.6 min after onset of OGD (Dave et al. 2009). Subsequent studies ruled out preservation
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of ATP levels, decreased excitatory amino acid release as mechanism of tolerance in 
AGS (Bhowmick et al. 2017b). Until now, it was unclear what mechanisms, downstream 
of depolarization and glutamate release, contribute to AGS resistance to cerebral I/R. 
Here, we tested the hypothesis that tolerance to I/R injury modeled in an acute 
hippocampal slice preparation in AGS is modulated by reduced oxidative and nitrative 
stress associated with OGD.
Our results confirm that at the tissue level, AGS tolerate OGD better than ischemic 
susceptible Sprague-Dawley rats. The tolerance to OGD in AGS is due to less oxidative 
and nitrative stress marked by reduced levels of 4-Hydroxynonenal (4-HNE) and 
nitrotyrosine (3-NT) generation. The findings suggest that tolerance to OGD in AGS is 
modulated in part by means to mitigate oxidative and nitrative stress.
4.3 Methods
4.3.1 Animal groups
Arctic ground squirrel (AGS, Urocitellus parryii) and Sprague-Dawley rats were 
used for these experiments. All procedures were performed in accordance with the 
University of Alaska Fairbanks Institutional Animal Care and use Committee (IACUC) and 
performed in accordance with the guidelines of the 8th edition of the Guide for the Care 
and Use of Laboratory Animals published by the US National Institutes of Health. 
Research was conducted in accordance with ARRIVE guidelines for reporting animal 
research (Kilkenny et al. 2010).
AGS of both sexes were trapped in the wild during mid-July in the northern foothills 
of the Brooks Range, Alaska, 40 miles south of the Toolik Field Station of the University 
of Alaska Fairbanks (68°38 N, 149°38 W; elevation 809 m). AGS were then transported
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to Fairbanks, AK under permit obtained from The Alaska Department of Fish and Game. 
Once transported, AGS were quarantined for two weeks and housed individually in 
facilities with an ambient temperature (Ta) of 16-18°C and a 12:12-h light-dark cycle. 
Food (rodent chow) was available ad libitum at all times. Experiments in AGS were 
conducted between July and September when AGS were in the summer euthermic state. 
Both males and females AGS were included in the study. Female AGS are reproductive 
only once a year in the spring. Neither males nor females were used during the breeding 
season. Male Sprague-Dawley rats (3-4 months of age at the time of the experiment) 
were purchased from Simonsen Laboratories (Gilroy, CA) and were transported by air to 
the University of Alaska Fairbanks. Rats were housed in groups of two to four at 20-21 °C, 
with a 12:12-h light-dark cycle. Only male rats were used to avoid the influence of estrous 
on the results. Ambient temperature and light-dark cycle remained the same for all 
groups. AGS and Sprague-Dawley rats weighing 389 -  1036g (701.54g ± 37.98) and 
300- 392g (401.35g ± 5.30), respectively, were used for the study.
4.3.1 Acute hippocampal slice preparation and in vitro modeled ischemia / reperfusion 
Animals were anesthetized using 5% (v/v) isoflurane with medical grade O2 at a 
constant flow rate of 1.5 L/min. Once unresponsive, the animals were euthanized via rapid 
decapitation and brains were removed within 2 minutes. The whole brain was then placed 
in ice chilled, oxygenated HEPES buffered artificial cerebral spinal fluid (HEPES-aCSF) 
containing 120 mM NaCl, 20 mM NaHCOs, 6.68 mM HEPES acid, 3.3 mM HEPES 
sodium salt, 5.0 mM KCl, 2.0 mM MgSO4 (pH 7.3 - 7.4) to attenuate edema during slicing 
and incubation. Rapidly dissected hippocampi were embedded in 2.5 % agar and 
transverse hippocampal slices, 400 jm  thick were cut at approximately 2°C in oxygenated
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HEPES-aCSF using a Vibratome® 1000plus sectioning system (The Vibratome 
Company, St. Louis, MO). The slices were then transferred to a brain slice keeper 
(Scientific Systems Design Inc., Mississauga, Ontario, CA) and allowed to recover for 1­
1.5 h at room temperature (20-21 °C) in HEPES-aCSF bubbled continuously with 95% O2/ 
5% CO2 before transferring to microperfusion chambers.
To address the time course of injury, treatment was applied using an in vitro 
microperfusion technique described previously (Kirschner et al. 2009) and validated for 
study of modeled I/R in rats (Bhowmick et al. 2017a). Briefly, after 1-1.5 h recovery as 
described above, individual slices were transferred gently to microperfusion chambers 
and lids sealed. The 4-8 parallel chambers (dimensions LxWxH~9x5x0.7 mm, 700 ^m 
deep with an additional with 0.3-mm deep microchannel support each with an estimated 
volume of ~ 35 ^L without tissue in place) were perfused with artificial cerebrospinal fluid 
(aCSF), pH 7.3 containing 120 mM NaCl, 45 mM NaHCO3, 10 mM glucose, 3.3 mM KCl,
1.2 mM NaH2PO4, 2.4 mM MgSO4, 1.8 mM CaCl2 bubbled with 95% O2 /5% CO2 and 
submerged in aCSF bath at 36°C (±0.2°C) at a flow rate of 7 ^L/min using Harvard 
Apparatus PHD 2000 syringe pump (Harvard Apparatus Holliston, MA). The osmolarity 
of these solutions was between 290 and 300 mOsm. Sampling began 75 min after 
submerging the sealed chambers to allow adequate time for stabilization of 
neurochemical efflux.
To model in vivo ischemia/reperfusion (I/R)-induced alterations in the ionic 
microenvironment, we perfused the hippocampus slices with one of the following, (1) 
aCSF, pH 7.3 as a control solution, (2) OGD, pH 7.3 (glucose-oxygen free aCSF). All 
aCSF solutions (pH 7.3) were equilibrated with 95% O2 and 5% CO2 whereas the OGD
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solutions were equilibrated with 5% CO2 and 95% N2, for a minimum of 1 h until pH 
stabilized in the desired range. The PO2 in OGD solution varied from 0-2.9 mmHg with 
an average of six determinations of 1.1 mmHg as measured using a miniature Clark-style 
electrode (Instech Laboratories, Plymouth Meeting, PA). The ischemia-induced alteration 
was made by switching the solution (from aCSF pH 7.3 to OGD pH 7.3) 8 min before the 
start of insult, the time it takes to completely replace the solution in the chamber with a 
flow rate of 7 jL/min. Perfusates were collected at 15 min intervals, and fractions were 
analyzed for cellular injury (LDH release) on the day of collection. Remaining volume was 
kept at -80°C for subsequent analysis.
Drug Treatment. To evaluate the role of NO, spermine NONOate (NO donor), or 
3-bromo-7-Nitroindazole (NOS inhibitor) (Cayman Chemical) was included in the 
perfusion medium with and without OGD. To evaluate the role of O2 - , hypoxanthine- 
xanthine oxidase (HX-XO) system was used to generate O2~: Bovine milk xanthine 
oxidase (>0.4 units/mg protein) and hypoxanthine (>99.0%) was obtained from Sigma. 
O2~ was decreased by the addition of the superoxide dismutase (SOD) mimetic 4- 
hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPOL) obtained from Sigma-Aldrich 
Corp. FetMPyP (Cayman Chemical), a synthetic porphyrin complexed with iron is an 
ONOO- decomposition catalyst and was used to decrease peroxynitrite in the 
microchamber.
4.3.3 Quantification of cell death
Lactate dehydrogenase (LDH) concentration in the perfusates was used as a 
marker of necrotic tissue damage. Fifty jL  of 105 jL  perfusates collected at 15min 
intervals was transferred to 384-well plates and mixed with 50 jL  reaction solution
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provided in the LDH assay kit (Cayman Chemical). After 60min incubation, optical density 
was measured at 490 nm using a microplate reader (BioTek Epoch). Background 
absorbance at 620nm was subtracted. The LDH release was expressed in arbitrary units 
per mg of protein (Biorad protein assay kit). The maximal releasable LDH was also 
obtained by treating the slices with 1% NP-40 lysis buffer (50 mM Tris-HCl, 0.5% sodium 
deoxycholate, 0.1% SDS, 1% Igepal, 150 mM NaCl, 0.05% Triton X-100) at the end of 
each experiment.
4.3.4 Determination of 4-hydroxynonenal protein adducts as a marker of lipid peroxidation
Following perfusion, each slice was homogenized in a ground glass homogenizer 
with 1% NP-40 lysis buffer, and the insoluble proteins were removed by centrifugation at 
4°C. Protein levels in an aliquot from each supernatant were measured according to the 
Bradford Assay. 4-Hydroxynonenal (4-HNE) levels were then determined by competitive 
ELISA from aliquots of the homogenate supernatants using a 96-well OxiSelect HNE 
Adduct Competitive ELISA Assay Kit (Cell Biolabs®, San Diego, CA, USA) according to 
the manufacturer's instructions.
4.3.5 Determination of 3-nitrotyrosine concentration as a marker of protein nitration
Acute hippocampal slices were homogenized on ice in 1% NP-40 lysis buffer. The 
slices were sonicated three times for 5 seconds each, centrifuged at 15,000g for 20 min 
at 4 °C. Finally, 3- nitrotyrosine (3-NT) concentrations were measured in supernatants 
using an OxiSelect™ Nitrotyrosine ELISA Kit (Cat. No. STA-305, Cell Biolabs, Inc., USA) 
according to the manufacturer's instructions. Briefly, 50 ^L of sample was added per well 
of ELISA plate and shaken for 10 min on an orbital shaker. Fifty ^L of anti-tyrosine 
antibody was then added and incubated for 1 h on an orbital shaker at room temperature.
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Then, each well was washed thoroughly three times with 250 ^L wash buffer. After 
removal of all wash buffer, 100 ^L secondary antibody-enzyme conjugate was added to 
all wells and incubated for 1 h at room temperature on orbital shaker. Again, each well 
was washed thrice with 1 * wash buffer. Substrate solution (100 ^L) was added to each 
well and incubated for about 15 min and as color developed 100 ^L of stop solution was 
added per well. Immediately the plate was read at 450 nm on a spectrophotometer using 
a microplate reader (Epoch Microplate Spectrophotometer, BioTek, Winooski, VT). 
Results were normalized per mg of protein.
4.3.3 Statistical analysis
A priori power analysis (G*Power software, (Faul et al. 2007)) was performed to 
estimate sample size needed to yield 80% power for detecting a significant (p<0.05) effect 
of treatment. An expected difference in means of 17.81 and standard deviations of 10.93 
and 2.24, taken from rat OGD and AGS OGD indicated that a sample size of 5 slices 
would have 80% power for detecting a difference. No animal was excluded from the study. 
Slices from animals were randomly assigned to treatment and control groups without prior 
knowledge to the treatment conditions. Data are expressed as a fraction of baseline 
values. Baseline was calculated as the mean of the two samples preceding the onset of 
treatment. Data processing and statistical analyses were performed using Microsoft 
Office Excel 2010 and Prism6 (GraphPad, San Diego CA, USA). Data were analyzed with 
one-way or two-way ANOVA with repeated measures or t-test where indicated. Significant 
main effects or interactions were followed by t-tests with Bonferroni's correction. Data are 
expressed as mean ± SEM, and P < 0.05 was considered statistically significant.
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4.4 Results
4.4.1 NO involvement in OGD injury
To illustrate that AGS tolerates OGD better than rat, hippocampal slices from a 
cohort of each species (rat and AGS) were exposed to 30 min OGD. Acute hippocampal 
slices from rat hippocampus exposed to OGD showed a significant increase in LDH 
release compared to control aCSF slices (p<0.0001, 2-way ANOVA, treatment x time, n= 
10-12 slices) (Figure 4.1a). Slices from AGS showed less LDH release than rat in 
response to OGD (p<0.0001, 2-way ANOVA, species x time, n= 9-12 slices) 
(Supplementary Figure 4.1). Nonetheless, release of LDH in response to OGD exposure 
in AGS was significantly greater compared to the control aCSF slices (p<0.0001, 2-way 
ANOVA, treatment x time, n= 9-16 slices) (Figure 4.1 d).
We next asked if NO is involved in OGD injury. The NOS inhibitor, 3-bromo-7- 
nitroindazole (IC50=17 ^M), eliminated OGD induced cell death in rat (p<0.0001, 2-way 
ANOVA, treatment x time, n = 7-12 slices) (Figure 4.1a), and AGS (p<0.0001, 2-way 
ANOVA, treatment x time, n = 7-9 slices) (Figure 4.1d). In rat, a significant difference was 
also noted in total LDH release measured as the sum of LDH released from the start of 
insult to the end of the experiment (p<0.0001, 1-way ANOVA, n= 7-12 slices) (Figure 
4.1b), however AGS showed no significant decrease in total LDH release in response to 
OGD (p=0.34, 1-way ANOVA, n= 7-9 slices) (Figure 4.1e).
Next, we ask if the NO donor spermine NONOate (10 ^M, T 1/2= 39 min) alone 
caused LDH release in rat and AGS. Spermine NONOate alone did not increase total 
LDH release measured as the sum of LDH released from the start of insult to the end of 
the experiment in either rat (aCSF vs. NO donor, p>0.0001, 1-way ANOVA, n= 7-10
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slices) (Figure 4.1 b) or AGS (aCSF vs. NO donor, p=0.41, 1 -way ANOVA, n= 7-16 slices) 
(Figure 4.1e). This indicates that NO donor alone is not sufficient to cause cell death. To 
test if exogenous NO would aggravate the OGD-induced injury, spermine NONOate was 
added to the OGD solution. Exogenous NO with OGD significantly increased total LDH 
release in rat compared to OGD alone (p<0.0001, 1-way ANOVA, n=7-12 slices). The 
response was concentration dependent with a plateau noted between 10 to 40 |jM (Figure 
4.1 c). By contrast, no significant increase in total LDH release was observed in AGS slices 
at concentrations up to 40 j M (p= 0.1, 1-way ANOVA, n=7-9 slices) (Figure 4.1 f). These 
results indicate that nitric oxide contributes to OGD-induced cell death in rat and that AGS 
resist NO-aggravated OGD-induced death.
We further analyzed the total LDH content per slice to ask if total LDH content 
limits the amount of LDH release following OGD. No difference in total LDH content was 
observed in slices from rat or AGS that were subjected to either aCSF or OGD treatment 
(Supplementary Figure 4.2). These results suggested that the difference in LDH release 
between rat and AGS not be due to a difference in total LDH content but is due to a 
difference in the injury associated with OGD exposure. As both males and females AGS 
were included in the study, we also compared LDH release between males and females 
to see if there is a significant sex difference on LDH release when subjected to OGD. No 
significant differences in LDH release were observed (Supplementary Figure 4.3).
4.4.2 O2 - involvement in OGD injury
To determine the role of O2 - mediated cell death at the tissue level, acute 
hippocampal slices from rat and AGS were subjected to O2" donor (HX-XO system -  0, 
15, 30, 45 mu/ml) with and without OGD exposure for 30 min. O2 - donor exposure alone
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caused a slight increase in LDH release in both rat (p<0.0001, 2-way ANOVA, treatment 
x time, n= 7-10 slices) (Figure 4.2a) and AGS (p<0.0001, 2-way ANOVA, treatment x 
time, n= 5-16 slices) (Figure 4.2c), however, when OGD was introduced along with O2 - 
donor, significant increase in LDH release was observed in rat (p<0.0001, 2-way ANOVA, 
treatment x time, n= 7-12 slices) (Figure 4.2b), but not in AGS slices (p=0.08, 2-way 
ANOVA, treatment x time, n= 6-9 slices) (Figure 4.2d). This indicates that rat is more 
vulnerable to O2 - aggravated OGD-induced cell death than AGS.
Next, we ask whether O2" causes OGD injury". Acute hippocampal slices from 
both rat and AGS were pretreated with the SOD mimetic (Tempol) along with OGD. The 
SOD mimetic significantly attenuates OGD mediated LDH release in the rat in a 
concentration-dependent manner (p<0.0001, 2-way ANOVA, treatment x time, n= 7-12 
slices) (Figure 4.2e). In contrast, tempol pretreatment along with OGD had no significant 
effect on LDH release in AGS (p=0.46, 2-way ANOVA, treatment x time, n= 6-9 slices) 
(Figure 4.2f).
We next asked if OGD injury involves ROS-mediated lipid peroxidation, a marker 
of oxidative stress. Results show a significant increase in total 4-HNE adduct formation 
in slices from a rat that was exposed to OGD as compared to aCSF treatment (p=0.02, t- 
test, n = 3-6 slices). However, no significant increase in 4-HNE adduct was observed in 
AGS slices that were exposed to OGD (p=0.4, t-test, n= 3-7 slices) (Figure 4.2g).
4.4.3 AGS are better protected from ONOO- mediated injury than rats
Since NO is known to react with superoxide anion at a diffusion-limited rate to form 
the short-lived, potent oxidant peroxynitrite, we next examined whether ONOO- was 
involved in OGD mediated cell death. Pretreatment of peroxynitrite decomposition
124
catalyst 5,10,15,20-tetrakis (W-methyl-4'-pyridyl) porphyrinato iron III (FetMpyp, 5 jM ) 
caused a significant reduction in LDH release in rat acute hippocampal slices that were 
exposed to OGD (p<0.0001, 2-way ANOVA, treatment x time, n = 7-12 slices) (Figure 
4.3a). By contrast, in AGS slices, pretreatment with the same concentration of FetMpyp 
had no influence on LDH release caused by OGD (refer to Figure 4 .1d) (p=0.11, 2-way 
ANOVA, treatment x time, n = 7-12 slices) (Figure 4.3b). This suggests that AGS resist 
peroxynitrite-mediated OGD injury.
We further examined the levels of 3-NT, a marker of peroxynitrite-mediated injury. 
Our results show that NO donor along with OGD increases 3-NT levels in slices from rat 
(p<0.0001, 1-way ANOVA, n= 6 slices) (Figure 4.3c). However, AGS slices show no 
significant increase in 3-NT levels with increasing concentrations of NO donor along with 
OGD (p=0.07, 1-way ANOVA, n= 3-6 slices) (Figure 4.3d). Similarly, the increases in 3- 
NT levels were much greater in rat slices that were subjected to increasing concentrations 
of the O2" donor along with OGD (p<0.0004, 1 -way ANOVA, n= 3-6 slices) (Figure 4.3e). 
By contrast, no significant increase in 3-NT level was observed in AGS slices exposed to 
O2" donor along with OGD (p=0.34, 1-way ANOVA, n = 3-5 slices) (Figure 4.3f).
4.5 Discussion
Here, we tested that tolerance to I/R injury modeled in an acute hippocampal slice 
preparation in AGS is due to protection from oxidative and nitrative stress associated with 
OGD. This study shows for the first time that in isolated acute hippocampal slices, AGS 
resist ONOO- induced lipid peroxidation and protein nitration injury during OGD. 
Moreover, we show that in rat both NO and O2~ are required for ischemia-modeled injury
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since neither alone was sufficient to produce an increase in LDH release similar in time 
course and magnitude to what is seen with OGD.
AGS tolerate cerebral ischemia/reperfusion caused by cardiac arrest or mimicked 
by in vitro preparations (Dave et al. 2006, Christian et al. 2008, Ross et al. 2006, 
Bhowmick et al. 2017b). AGS hippocampus resists up to 2h of OGD (Christian et al. 
2008), despite anoxic depolarization (Dave et al. 2009). Subsequent studies ruled out 
preservation of ATP levels or decreased excitatory amino acid release as mechanisms of 
tolerance (Bhowmick et al. 2017b). Until now, it was unclear what mechanisms, 
downstream of anoxic depolarization and glutamate release, contribute to AGS resistance 
to cerebral I/R. We now know that detoxification of ONOO- contributes to ischemia 
tolerance in AGS. We interpret the mechanism as detoxification because resistance to 
OGD coupled with NO was not lost at high concentrations of NO donor. We identify 
ONOO- as the damaging species in rat because both NO and O2 - were required for injury. 
NO and O2~ donors paired with OGD exacerbates cell death in rat, but neither one alone 
is sufficient to induce cell death in rat or AGS. We interpret results to indicate that OGD 
generates the endogenous NO and O2~ that when combined with exogenous NO or O2~ 
produces ONOO- and causes injury.
We know from prior studies in rat that one of the responses to cerebral ischemia 
is an increase in the production of NO, catalyzed by nitric oxide synthase (NOS) (Zhang 
et al. 1995). Recent studies demonstrated that excessive levels of NO generation due to 
NOS activation cause cell and tissue damage (Murphy 1999, Kader et al. 1993, Zhang et 
al. 1995, Zhang et al. 2008). Injury associated with NO can be related to either NO itself 
or be due to the interaction with O2~ forming ONOO- (Zielonka et al. 2010). Inhibition of
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NOS has been reported to protect against ischemia mediated neurotoxicity (Hamada et 
al. 1994, Trifiletti 1992). Our results are in accord with previous studies that inhibition of 
NOS reduces production of NO during OGD and significantly decreases cell death in rat 
(Murphy 1999, Scorziello et al. 2004, Lu et al. 2015). There has been long debate as to 
whether NOS isoforms are activated during ischemia since the generation of NO via 
activation of NOS requires O2 as a substrate (Forstermann & Sessa 2012). However, 
there are substantial evidences that NO increases at 2-6 min after middle cerebral artery 
occlusion and in the first 10 min of OGD in the cultured hippocampus (Zhang et al. 1995, 
Chan 1996). NO synthesized by different NOSs has controversial effects during cerebral 
ischemia. Previous studies have determined that NO derived from the endothelial NOS 
(eNOS) is beneficial in acute ischemia. In contrast, NO produced by the neuronal NOS 
(nNOS) and inducible NOS (iNOS) can be neurotoxic (Willmot et al. 2005). Our approach 
targeted nNOS as other results showed that use of selective nNOS inhibitors, or nNOS 
‘knock-out’ mice, led to substantially lower infarct volumes during cerebral ischemia 
(Murphy 1999). By contrast, iNOS becomes upregulated from 12 hours after middle 
cerebral artery occlusion (MCAO) for up to 7 days (Niwa et al. 2001). For this reason, we 
used an inhibitor of nNOS 3-bromo-7-nitroindazol (0.17 jM ) (IC50 = 0.17 jM). However, 
because 3-bromo-7-nitroindazol inhibits iNOS (IC50 = 0.29 jM ) and eNOS (IC50 = 0.86 
jM ) (Babbedge et al. 1993) at slightly higher concentrations, we cannot rule out 
involvement of eNOS and iNOS isoforms. Resistance to OGD in AGS did not depend on 
lack of NOS activation since NOS inhibition eliminated the small amount of OGD-induced 
injury in AGS. Although this injury was much less in AGS than in rat, both were eliminated 
by NOS inhibition, so both involved NOS activation.
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Increase in LDH release when exogenous NO is paired with OGD but not alone 
also reflects that NO combines with a reactive species generated during OGD that 
together contributes to cell death. In our study, a nitric oxide donor, spermine NONOate 
((Z)-1 -[N-[3-aminopropyl]-N-[4-(3-aminopropylammonio)butyl]-amino]diazen-1 -ium-1,2- 
diolate) was chosen as an exogenous source of NO due to its simplicity in handling, 
storage stability and its convenient half-life in solution (about 39 min at 37°C). Spermine 
NONOate decomposes in solution producing 2 moles of NO per mole of the parent 
compound. In our microperfusion approach, the time taken for the perfusion solution 
containing spermine NONOate to reach the slice is 8 min. We therefore, do not know the 
actual concentration of NO in the slice, but are confident based on observations that 
spermine NONOate exacerbated OGD-induced injury in rats that the concentration and 
time of NONOate to reach the slice was sufficient to increase NO levels in the slice.
Generation of O2~ could be limited during OGD due to decreased availability of
O2. We do not think this is the case because other results support that O2~ generated 
and monitored during OGD in rat is cytotoxic (Lu et al. 2012) and cell death during OGD 
is attenuated by a SOD mimetic (Tempol) (Lahiani et al. 2016). Tempol is a membrane- 
permeable, SOD mimetic that catalyzes the reduction of O2~ to H2O2 (Salvemini et al. 
2002). As an SOD mimetic, Tempol metabolizes O2~ generated in solutions of xanthine 
plus xanthine oxidase (Patel et al. 2006) and is neuroprotective against O2 - and ONOO- 
- induced inflammation (Khattab 2006). Recently the specificity of Tempol for O2~ has 
been questioned since it also reduces the formation of hydroxyl radicals (Mitchell et al. 
1990, Monti et al. 1996) and attenuates the cytotoxic effects of H2O2 (Chatterjee et al. 
2000). Tempol also inhibits ONOO--mediated nitration of tyrosine (Carroll et al. 2000).
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The lack of specificity of tempol to reduce O2~ does not change our interpretation that 
O2~ alone is not the damaging species during OGD. We base this conclusion on the 
observation that the generation of O2~ by hypoxanthine plus xanthine oxidase produced 
a negligible increase in cell death. Only when combined with OGD did O2~ produce 
pronounced cell death and OGD-induced cell death was blocked by Tempol.
During I/R injury, three distinct mechanisms generate ROS contributing to cell 
death: mitochondrial ROS generation, xanthine oxidase (XO) system and the NADPH 
oxidase complex. The paradox of increased O2 - production during ischemia is 
counterintuitive since O2 levels are decreased during ischemia, and ROS generation 
increases during the reperfusion phase when there is a high influx of O2. However, the 
rate of O2 - generation is affected both by O2 level and the availability of reduced flavins 
and quinones capable of acting as a source for univalent electron transfer. The tendency 
of reduced flavins to increase O2~ production at lower O2 concentrations was previously 
described (Misra & Fridovich 1972). During ischemia, mitochondrial electron transport 
slows, augmenting the reduction state of electron carriers. This favors O2~ generation if 
some O2 is still available. Our approach shows that an SOD mimetic (Tempol) attenuates 
OGD induced cell death suggesting that during OGD there is generation of O2 - which is 
in accord with previous work showing that increased mitochondrial ROS generation 
occurs only during the first few minutes of hypoxia (Abramov et al. 2007). Increase in 
LDH release in rat when O2 - donor was paired with OGD also support that O2~ 
contributes to ONOO- mediated cell death whereas AGS resist this scenario. In our study, 
HX-XO system was used to generate O2 - although under most conditions xanthine 
oxidase generates more H2O2 than O2~ (Cantu-Medellin & Kelley 2013). For this reason,
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we cannot rule out that H2O2 may react with a species generated during OGD. This is 
less likely to be the fate of H2O2, however, because H2O2 is less reactive than O2~ 
(Kalogeris et al. 2014). O2~ generated during ischemia undergoes rapid dismutation to 
H2O2 by SOD. However, since NO is also generated during OGD, the presence of NO in 
close proximity to O2 - favors the formation of ONOO- over H2O2 since the rate constant 
of NO with O2~ is larger than with SOD and therefore NO outcompetes SOD for O2~ 
(Fridovich 1995, Ferrer-Sueta & Radi 2009). This mechanism explains why O2 - formation 
by xanthine oxidase is sufficient to mediate alterations in vascular function by reducing 
NO bioavailability via direct reaction (NO + O2 - ^  ONOO-) (White et al. 1996).
Our results support a dominant role for ONOO- in OGD -induced injury because 
when FetMPyP, a peroxynitrite decomposition catalyst (PDCs) was used, LDH release 
was significantly reduced in rat. FetMPyP exhibits good specificity as a peroxynitrite 
decomposition catalyst with an EC50 value of 3.5 jM  (Salvemini et al. 1999), and does 
not influence NO or O2 - action (Misko et al. 1998, Salvemini et al. 1998, Salvemini et al. 
1999, Xie et al. 2002). We used FetMPyP at a concentration of 5 jM  as this concentration 
is near the EC50 value and was shown previously to be efficacious in ONOO- 
decomposition (Jensen & Riley 2002, Stern et al. 1996). Furthermore, rat slices subjected 
to OGD in presence or absence of NO/O2 - increases 4-HNE adduct and 3-nitrotyrosine 
level. Both 4-HNE adduct and 3-nitrotyosine are generated in the presence of ONOO- 
(Hall et al. 2004, Xiong et al. 2007). Although the biomolecular modifications are not 
specific markers of ONOO- they are consistent with the presence of ONOO- and in light 
of other results discussed above support the interpretation that injury is due to ONOO-.
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Our results support that the increase in cell death is due to a direct bimolecular 
reaction of NO with O2~ generated during OGD which others have shown to yield 
ONOO- at almost diffusion-limited rates (rate constant (k)=6.7 -  19 * 109/M/s) 
(Jourd'heuil et al. 2001, Reiter et al. 2000). By rapidly consuming O2~, NO produces 
ONOO-/ONOOH. ONOO- is a potent oxidant that plays a critical role in neurotoxicity of 
NO and O2 - (Pacher et al. 2007). ONOO- can easily cross the plasma membrane and 
oxidize many intracellular molecules including lipids, DNA and proteins (Szabo et al. 
2007), subsequently inducing protein dysfunction and DNA damage, and cell death (Radi 
2004). Previous studies also indicate that ischemia causes an increase in levels of NO, 
O2~ and ONOO- concentrations in the brain from basal levels of 1-10 nM (Halliwell et al. 
1999) to the low ^M range (Lipton 1999) with subsequent protein nitration and cellular 
injury (Eliasson et al. 1999). Our results are consistent with other studies suggesting that 
excess NO radical in the presence of O2 - is neurodestructive (Dawson et al. 1993). Other 
studies in human neuroblastoma cells also reported that when NO donor was applied 
along with nontoxic concentrations of H2O2 (an oxidative stress), neurotoxicity due to the 
formation of ONOO- was observed (Tajes et al. 2013). Resistance to cell death in AGS 
associated with NO or O2~ donor with OGD suggests that AGS avoids this mechanism 
of injury that is deleterious in rat. Pretreatment with FetMPyP during OGD further confirms 
that ONOO- is generated during OGD (Thiyagarajan et al. 2004) causing lipid peroxidation 
and protein nitration, markers of ONOO- mediated cell death (Hall et al. 2004). Lower 
levels of lipid peroxidation and protein nitration in AGS suggest that AGS resist ONOO- 
induced cell death.
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The microperfusion technique (Kirschner et al. 2009) used in the present study 
was developed specifically for the study of OGD in adult brain slices. Constant perfusion 
of slices with aCSF maintains slice integrity for ~8 hours. This approach was used 
previously to monitor glutamate and adenosine release in rat slices during OGD 
(Bhowmick et al. 2017a). We acknowledge that the in vitro approach used for our study 
might not apply to the in vivo scenario wherein whole animal mechanisms such as pH, 
buffering capacity and limited inflammatory response contribute to tolerance to ischemia 
reperfusion injury (Bogren et al. 2014b). However, this approach isolates mechanisms 
intrinsic to hippocampus and allows for each component to be manipulated in the 
ischemic cascade to study mechanisms at the tissue level. The approach allows for the 
study of cell death in adult AGS tissue. Although the time constraint in tissue viability in 
our approach limits the study of apoptotic cell death that is possible with organotypic brain 
slice culture, capacity to study adult tissue is an important advantage since AGS are 
seasonal breeders which limits availability of neonatal tissue for organotypic culture 
(Fukuda et al. 1995). Another advantage with this approach is that cell death can be 
monitored by capturing LDH release (Chan et al. 2013) from the entire slice and thus 
overcomes the limitations of methods used in prior studies where high baseline cell death 
could have compromised interpretation (Ross et al. 2006, Christian et al. 2008). Finally, 
the method provides some temporal resolution to study the time course of cell death.
Our experimental approach reduces animal numbers and refines techniques as 
per the ARRIVE guidelines. We have chosen the slice model for our study because brain 
tissue is a complex collection of neurons and glia that cannot be modeled entirely using 
cell culture. Cell and tissue culture differ from adult brain slices in several ways such as
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the influence of age (adult vs. neonatal) on the mechanisms of resistance, the proportion 
of neurons to glia, synaptic connections between neurons, neural circuitry that affects 
metabolic demand of the tissue and maturity of the neurons studied. However, the slice 
model reduces the number of animals used and refines the experimental approach to 
minimize animal pain and suffering associated with whole animal studies. The 
microperfusion technique also refines the approach to the study of brain injury by 
providing a time course of acute injury that has not been possible to date with cell and 
tissue culture.
4.6 Conclusions
In summary, our data supports that NO and O2~ alone are not causing injury in rat 
or AGS because neither produced significant injury except when paired with OGD. OGD 
injury is caused by the release of both NO and O2~ and one without the other is not 
sufficient to induce cell death. Our data suggests that the injury is due to the combination 
of NO and O2 - together forming ONOO- leading to cell death. We interpret these findings 
to mean that resistance to injury in AGS is associated with reduced susceptibility to highly 
reactive ONOO- generated during I/R injury.
4.7 Acknowledgements
This work was supported by the US Army Medical research and Material Command, No 
0517800; the National Institute of Neurological Disorder and Stroke, Nos. NS041069-06 
and R15NS070779; Institutional Development Award (IDeA) from the National Institute of 
General Medical Sciences of the National Institutes of Health under grant number 
P20GM103395.
133
Figure 4.1: AGS resist nitric oxide mediated LDH release.
(a, d) Slices from rats and AGS were subjected to 30 min of aCSF, OGD, and OGD + 
NOSI. The time course of LDH release is shown. *p< 0.05 (aCSF vs. OGD), #p<0.05 (OGD 
vs. OGD + NOSI). (b, e) Total LDH (the sum of LDH released from the start of insult to 
the end of the experiment) is shown in a and b. *p< 0.05 vs. aCSF, +p<0.05 vs. NO (10 
j M), #p<0.05 vs. OGD + NOSI. (c, f) Total LDH release from additional experiments in 
which NO donor was included with OGD. *p< 0.05 vs. OGD. Grey bar indicates insult 
period.
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Figure 4.2: AGS show better tolerance to O2 - mediated cell death.
(a, c) Acute hippocampal slices from both rat and AGS were subjected to different 
concentrations of O2" donor (HX-XO: 0, 15, 30, 45 mU/ml) and LDH release over a course 
of time was monitored. *p< 0.05 (0mU/ml vs. 45mU/ml), +p<0.05 (0mU/ml vs. 30mU/ml). 
(b, d) Time course of LDH release was monitored in rat and AGS slices exposed to 
different concentrations of O2 - donor (HX-XO: 0, 15, 30, 45 mU/ml) along with OGD. *p<
0.05 (OGD+0mU/ml vs. OGD+45mU/ml), +p<0.05 (OGD+0mU/ml vs. OGD+30mU/ml). 
(e, f) Acute hippocampal slices from rat and AGS pretreated with SOD mimetic (tempol) 
followed by OGD. *p<0.05 (OGD vs OGD+Tempol (3mM)), +p<0.05 (OGD vs 
OGD+Tempol (0.03mM)) (g) shows total 4-HNE-Protein adduct formation in rat and AGS 
slices exposed to OGD *p< 0.05 vs. aCSF.
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Figure 4.3: AGS tolerate peroxynitrite mediated OGD injury.
(a, b) rat and AGS slices were preincubated with FetMpyp (peroxynitrite decomposition 
catalyst) and LDH release was monitored. *p< 0.05 vs. OGD. (c, d) 3-NT was measured 
in rat and AGS slices subjected to NO donor along with OGD. *p< 0.05 vs. OGD, +p<
0.05 vs. aCSF. (e, f) 3-NT was measured in rat and AGS slices when subjected to O2" 
donor along with OGD. *p< 0.05 vs. OGD.
136
Supplementary Figure 4.1: Comparison of OGD injury in male and female AGS
Slices from rats and AGS were subjected to 30 min OGD. The time course of injury (LDH 
release) is shown. *p< 0.05 vs. OGD, 2-way ANOVA, species x time, n= 9-12 slices. Grey 
bar indicates insult period. Data shown are means ± SEM.
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Supplementary Figure 4.2: Measurement of total LDH content in rat and AGS
Total LDH content per slice from rat and AGS were subjected to 30 min of either aCSF 
or OGD treatment. At the end of each experiment, slices were homogenized and total 
LDH content per slice was measured. Data shown are means ± SEM.
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Supplementary Figure 4.3: LDH release monitored in male and female AGS subjected to 
OGD
Male and female AGS hippocampal slices were subjected to 30 min No significant 
differences in LDH release was observed (p>0.9999, 2-way ANOVA, Sex vs. time). Grey 
bar indicates insult period. Data shown are means ± SEM.
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Chapter 5: General conclusion
Cardiovascular accidents characterized by ischemia/reperfusion (I/R) injury such 
as stroke and, cardiac arrest pose severe medical complications. Mammals capable of 
hibernation represents a robust example of tolerance to I/R injury that is unmatched by 
any other model of ischemia tolerance. Obligate hibernators such as arctic ground squirrel 
may hold insight into possible interventions to ameliorate disorders characterized by I/R 
injury. To date, researchers have explored several factors associated with hibernation 
such as hypothermia, hypometabolism, high base excess that might contribute to I/R 
tolerance in hibernating animals. However, in the whole animal model, it is difficult to 
isolate neuroprotective factors at the tissue level that provides tolerance to I/R injury.
Through this thesis work, I have demonstrated that a microperfusion approach 
provides better temporal resolution of I/R injury that leads to decipher the complex 
interactions of glutamate-mediated excitotoxicity with acidosis-mediated acidotoxicity and 
to understand the role of acid-sensing ion channels (ASIC1a) and pH in mediating cellular 
injury during ischemia. In addition, the thesis demonstrates that hibernation season or 
state is not essential for resistance to ischemic injury in AGS. Rather, resistance is 
associated with reduced susceptibility to highly reactive ONOO- generated during I/R 
injury.
Herein, in chapter 2, I validate a novel in vitro microperfusion approach to study 
I/R injury and demonstrate that oxygen glucose deprivation (OGD) injury modeled in rat 
acute hippocampal slice mimics in vivo I/R conditions such as ATP depletion and the 
overflow of neurotransmitters and neuromodulators such as glutamate, aspartate and 
adenosine. This approach also validates that injury associated with low pH or OGD occurs
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during the insult phase and not during the reperfusion phase which is not possible to 
decipher in vivo. Under in vivo cerebral I/R, as the multiple events occur concomitantly, it 
is not possible to evaluate the role of each component of the ischemic cascade and their 
interaction during the event of I/R injury. Traditional in vitro slice preparations do not 
produce the same changes in the extracellular milieu as what occurs in vivo because of 
rapid washing with a highly-diluted bath solution. In the present study, the microperfusion 
approach provides a better tool for monitoring temporal resolution of injury as well as the 
overflow of metabolites and neurotransmitters and allows for manipulation of each 
component of the ischemic cascade to better understand interaction during I/R injury.
During a stroke or cardiac arrest, tissue acidosis (low pH) and excitotoxicity 
(glutamate receptor-mediated cell death), both occur concomitantly. However, in the 
whole animal model, it has not been possible to separate the effects of low pH from 
glutamate mediated excitotoxicity. In chapter 2, I, therefore, investigated the effect of 
acidosis on glutamate-mediated excitotoxicity in acute hippocampal slices to resolve the 
controversy regarding the relative importance of acidotoxicity and NMDAR mediated 
excitotoxicity. Using a novel microperfusion technique, I separated the effects of pH and 
oxygen glucose deprivation and showed that injury caused by oxygen glucose deprivation 
without low pH is caused by stimulation of NMDA glutamate receptors. However, when 
low pH was added to the insult, as would occur during a stroke or cardiac arrest, low pH 
abolished the injury caused by stimulation of glutamate receptors but produced its own 
type of injury. Furthermore, I show that damage resulting from low pH was due to 
activation of acid sensing ion channels (type 1a). These findings argue that activation of 
acid sensing ion channels produce brain injury during cerebral I/R and help to explain
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why clinical trials using drugs that block glutamate NMDA receptors failed to protect 
stroke patients.
In chapter 3, I show that tolerance persists in AGS hippocampal slices obtained 
from summer and winter (hibernating and interbout arousal) animals subjected to OGD 
at 36°C. This reflects that tolerance persists independently of the hibernation season or 
state as well as cold tissue temperature. This suggests that AGS exhibit tolerance at the 
tissue level and may be unique compared to other hibernating species in the lack of 
seasonal dependence on ischemic tolerance. Moreover, AGS are highly tolerant to OGD 
compared to ischemic susceptible Sprague-Dawley rat despite the loss of ATP, excitatory 
amino acid release, and acidosis and persists during conditions that mimic acidosis and 
ischemic shift characteristics of cerebral I/R injury. Taken together, this study suggests 
that tolerance to I/R injury in AGS resides downstream of or is independent of glutamate 
release.
Oxidative and nitrative stress has long been associated with I/R injury. Chapter 4, 
shows for the first time that at the tissue level, during modeled ischemia in rat 
hippocampus, injury is caused by peroxynitrite (ONOO-) that requires both nitric oxide 
(NO) and superoxide (O2~); neither species was injurious alone, but both exacerbated 
injury caused by oxygen glucose deprivation. My data suggest that the injury is due to the 
combination of NO and O2 - together forming ONOO- leading to cell death. This work 
identifies for the first time a mechanism that is absent in the I/R cascade that can explain 
resistance to injury in the arctic ground squirrel and will provide novel avenues for 
translating protection from ONOO- injury in humans.
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Unlike mammalian hibernators, humans suffer consequences in response to 
limited blood flow where they experience significant injury in response to ischemia and 
reperfusion. Currently, much is known about these mechanisms, however, no therapeutic 
has emerged from this understanding. A clear understanding of the degree of ischemia 
tolerance hibernating animals display opens the door for further in depth mechanistic 
studies. A better understanding of regulatory mechanisms will guide discovery of 
therapeutics designed to mimic natural means of ischemia tolerance.
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Western blots were performed to compare the expression of Ngb in cortex and 
hippocampus of Rats and AGS. Results showed that in the cortex, Ngb expression in 
AGS is higher as compared to rat (n=6, p<0.003); cortex of winter AGS (wAGS) shows 
higher level of Ngb expression than summer AGS (sAGS) (n=4, p<0.0045); no significant 
difference in Ngb expression in hippocampus of winter AGS versus summer AGS (n=6, 
p<0.24).
A p p e n d ix  A  2: N eu rog lob in  exp ress ion  in A rc tic  g round  squ irre l
17 kDa
<-----  42 kDa
R = Rat 
A = sAGS
Figure A1. Ratio of Ngb density to actin is significantly greater in cortex of sAGS versus 
Rat (P<0.0003). Ngb antibody (FL-151): sc-30144 (Santa Cruz Biotechnology).
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S = sAGS 
W = wAGS
17 kDa 
42 kDa
Figure A2. Ratio of Ngb density to actin is significantly greater in cortex of wAGS versus 
summer euthermic AGS (P<0.0045). Ngb antibody (FL-151): sc-30144 (Santa Cruz 
Biotechnology)
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Figure A3. No significant difference in Ngb in hippocampus of summer euthermic AGS 
versus winter AGS (P<0.24). Ngb antibody (FL-151): sc-30144 (Santa Cruz 
Biotechnology)
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Figure A4. Validation of Ngb in AGS using Anti-Ngb [13C8]- Azide free (ab37258) 
Antibody.
Conclusion: The objective of the research is to identify the role and mechanism of Ngb in 
increasing resistance to cerebral I/R injury by using a natural model of high tolerance to 
ischemia. Results show that ischemic tolerant species, AGS constitutively express high 
Ngb level as compared to susceptible species, rats. However, I could not proceed with 
the experiments to decipher the role of Ngb in ischemia tolerance in AGS because the 
antibody (sc-30144) was discontinued. Another antibody 13c8-Azide free (ab37258) from 
Abcam showed bands at 17 kDa, but positive control produced two large bands and 
experts in the field questioned the specificity of this antibody. I did not have resources to 
validate specificity so did not pursue further investigation of Ngb.
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I. Assembling Plate:
1. Wash and clean the plates with 70% ethanol and with detergent if needed.
2. Place into casting tray in upwards direction and close the notch.
3. Add distilled water to check leakage for 10 Sec.
4. Pour off the water and wipe at the corner by Kim wipe or by using a vacuum pipette.
5. Mark 1cm below comb = height of separating gel (a scale with mark is already 
there)
II. Preparation and pouring of gel:
1. Separating gel/ Resolving gel:
a. While assembling the plate, take the acrylamide out of the fridge and let it warm
up. Also, get an aliquot of APS from the freeze and let it thaw.
b. Recipe for gels with different % acrylamide is listed in reagent section. Add the
reagent in the ordered list.
c. Pour the separating gel mix using a pipet between the plates up to the mark plus
some to allow for shrinkage. Touching the pipet to the back plate will ensure 
smooth pouring and avoid bubbles.
d. Using a pasteur pipette, gently but quickly overlay the acrylamide mix with ~ 0.5-1
ml of isopropanol.
e. Allow it to solidify for 15- 20 Min. and check by looking at the remaining gel in the
tube. N.B. Keep the cap open.
f. Once the gel is polymerized, rinse the isopropanol gently with milliQ H20 using a
P-200 tip attached to the suction tube and ensure all the isopropanol is removed.
A p p e n d ix  A  3: W e s te rn  b lo t p ro toco l
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2. Stacking gel:
a. While separating gel is solidifying, make 4.5% stacking gel in a 50ml centrifuge tube. 
Combine all reagents for stacking gel in the order the ordered list except APS and 
TEMED.
b. Find the appropriate comb to make the wells for the gel and rinse it off.
c. Pour the gel and quickly insert the comb, trying not to get any bubble beneath the
comb. It is OK if extra acrylamide spills over the edge. Do this on a paper towel. Work 
quickly because the stacking gel will polymerize within a few minutes.
d. Wait 10 Min. for the gel to solidify and check by looking at the remaining gel in the 
tube. N.B. Keep the cap open.
III. Preparing sample: (Sample + sample buffer + dH2O)
1. While the stacking gel is polymerizing, turn on the boiling water bath.
2. Thaw the sample if previously frozen.
3. Make up gel standards (same volume of sample buffer + 1 ^l of either high or low
unstained MW standards).
4. Boil all samples for 5 minutes. Do not boil positive control -- 30 sec only.
5. Let samples cool for a minute, and then do quick spin in centrifuge to get liquid to 
bottom of tube.
IV. Setting up Gels and Loading samples
1. Wipe the plates and load onto the electrophoresis unit along with the Dam Plate 
or 2nd plate, if available, by holding the plates down and clamping it.
2. Pour 1X running buffer into upper and lower (just above lower screws) chambers
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3. Carefully remove comb, running buffer will flow into wells and rinse out 
unpolymerized acrylamide.
4. Using a pasteur pipette and gel loading tip, get rid of any air bubble and 
unpolymerized acrylamide inside the well.
5. Load the samples using P-200 and gel loading tips. Place the tip close to the 
bottom of the well. the sample is denser the running buffer and will sink to the 
bottom of the well. Be careful not to expel a big air bubble at the end and avoid 
forcing sample out of the well.
6. When all samples are loaded, place the cover on the gel box.
7. Turn ON the power supply.
V. Gel Running Conditions: (Choose one of the following)
1. Run sample into gel at 100V, then turn upto 150 if hooked to a cooling system. Check 
to make sure samples are running down. At 150 V, running takes about 1-1/4 hours
2. For overnight, run at 20-30 V. In the morning, turn up the power to 200 V for a while to 
refocus the bands.
Gel running continued.....
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a. Run gel until dye front is near the bottom
b. Turn off the power supply
c. Place the gel box in a pan and remove the connection to the water circulation.
d. Undo the clamps and remove the gel plates
e. Using a spacer, pry apart the plates. the gel should stick to one plate or the other. 
keeping gels on shorter plate gives membrane orientation with broad standard on 
left.
f. Gently remove the stacking gel using the spacer.
g. If you are going to dry the gel, place the gel into Coomassie blue stain. If you are
going to do a transfer, you should have already set up the transfer cassette.
h. Turn the plate upside down over the transfer cassette, prod the gel with the spacer 
and let it fall into the buffer.
VI. Mini-gel transfers to nitrocellulose:
1. While gel is running:
a. Make sure there is enough transfer buffer or make more.
b. Get pan for assembling sandwich and rinse with distilled water.
c. Get transfer box, cassettes, sponges and rinse with distilled water.
d. Get filter forceps and rinse.
e. Cut 4 pieces of 3MM filter paper per gel to 6 x 9 cm
f. Cut nitrocellulose to 5.5 x 8 cm. Equilibrate in transfer buffer for 30 min before 
transfer.
2. Assemble sandwich - wear gloves!
a. Take the transfer cassette and arrange in the following order....
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Black Side < Sponges < Filter Paper < Gel || Membrane > Filter Paper > 
Sponges > Transparent Side.
b. Place gel on 3MM filter paper. Gel should be placed down so that blot comes out 
with same orientation as loaded. Smooth out with fingers.
c. Label upper right hand side of nitrocellulose to maintain orientation. Use forceps 
to place nitrocellulose on gel. Run spacer over it to get rid of bubbles.
d. Close cassette and put in transfer box with black side of cassette facing the black
side of the transfer box insert.
e. Put white plastic insert with ice into transfer box.
f. Fill transfer box with transfer buffer.
3. Transfer parameters:
a. Run at 70 volts for 75 min. Starting current =190 mA for 2 gels. Equipment can 
also be set to run by amps. Check to make sure current is flowing.
b. To transfer overnight, run at 20-30 V. Omit ice insert.
c. Take out the cast and look for the ladder.
VII. Protein Identification:
1. Take the blocking buffer (5%milk/ TBS) in a box and incubate the membrane in it for
1 Hr. at room temperature on orbital shaker.
2. Pour off the blocking buffer and incubate the membrane with primary antibody
overnight at 40C.
3. Remove the primary antibody by pipette and micro syringe and keep in the original
tube for future use.
4. Rinse with TBS-Tween (TBST) X 2.
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5. Wash with TBST...... X 4, 15 min each (shaker).
6. Incubate with secondary antibody at room temperature for 1 Hr. in shaker.
7. Rinse with TBS-Tween (TBST) X 2.
8. Wash with TBST...... X 4, 15 min each (shaker).
9. Discard the washing buffer and add chemiluminescense Compound for HRP by
spraying enough to cover the membrane.
10. Take the membrane out, wipe off the extra substrate by wrapping in Kimwipe, and 
wrap in a plastic film.
11. Take the autoradiography cassette, stick a ruler to it, and charge it by keeping in light.
12. Put the membrane on one corner of the autoradiography cassette by sticking to a 
tape and take to dark room for development along with the films.
13. In the dark room activate the machine first and keep the film in the autoradiography 
cassette for varying periods of time and develop the autoradiograph.
14.A molecular marker (Biorad Precision Plus Protein™ Kaleidoscope™ Prestained 
Protein Standards) and positive control (Ab63278) is used to determine the molecular 
weight of the target protein (Ngb).
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1. Identify animal to be used -  Rat #_______________
2. Calibrate pH meter using fresh standards.
3. Prepare 1 L HEPES-aCSF*, bubble vigorously with 95% O2/5%CO2 at RT until 
pH is 7.3-7.4, at least 30 minutes.
4. Turn on one hot water bath to 36°C.
5. Prepare 2 L aCSF* to fill microperfusion water bath. Bubble vigorously with 95% 
O2/5%CO2 at 36°C.
6. Prepare 100 mL aCSF * and 100 mL low pH aCSF*. Filter, bubble vigorously 
with 95% O2/5%CO2 at 36°C. Record pH when stable.
7. Prepare 100 mL OGD *. Filter, bubble vigorously with 95% N2/5%CO2 at 36°C. 
Record pH when stable.
8. Turn on cooling bath fo r vibratome (-7.7°C).
9. Set up for dissection. Prepare slice chamber for Hepes recovery at RT, bubble 
with 95%O2/5%CO2.
10. Prepare 2 ml homogenization buffer**.
11. Pour Hepes-aCSF into vibratome bath (add blade!), beaker for brain rinse, and 
petri dish for hippocampus. Allow to cool fo r 30 minutes.
12. Set up oxygen electrode. Calibrate using dH2O for gain, dH2O+sodium dithionite 
for zero. Keep in dH2O at RT.
13. Weigh out 1.25g Agar, add 50ml of HEPES-aCSF. Add stir bar, place in water 
on hot plate and cover with foil. Start hot plate at setting 4 and stir when 
vibratome bath is at 3°C.
A p p e n d ix  A  4: A cu te  s lice  p repa ra tion  and m ic rope rfus ion  p rocedu re
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14. When vibratome bath temperature reaches 2°C, anaesthetize animal with 
Isoflurane. Weigh animal and record body/temporalis temperatures.
15. Decapitate animal. Extract brain on ice, place in cold HEPES-aCSF for 40 
seconds.
16. Pour heated agar into a Petri dish.
17. Dissect brain on ice. Place 1 hippocampus in a covered Petri dish with cold 
HEPES-aCSF while agar cools to 40°C.
18. Embed one hippocampus in agar, lined up, cool on ice until agar solidifies.
Cut agar/hippocampus block to mount on vibratome block with tissue adhesive. 
Adjust Hepes-aCSF volume in vibratome. Adjust bubbling in vibratome and slice 
chambers. Slice 400um thick sections at speed setting 6, amplitude max (10).
19. Remove agar from slices and transfer slices to RT Hepes brain slice chamber.
20. Allow slices to recover fo r 1 hour 20 min at RT, bubbling continually.
21. Transfer and load the slices into micro perfusion chambers for treatment 
* Solutions
Add to Graduated 
Cylinder
100 mL 
Low-pH 
OGD
LOO mL 
Low-pH 
aCSF
100 mL 
aCSF
2LaC5F 
For LDH
1 L
HEPES-aCSF 
[on ice)
Milli-Q H2D “ B0 mL ™SC mL “ SO mL 1600 ml ■“SCO ml
Buffer 10 mL 10H 
low pH 
aCSF
10 mL10X 
1 zfi oH 
aCSF
10 ml lOxaCiF 2CO ml 
10k aCSF
100 ml 
1C k hepes
0.5M CaCIZ 360 u 360 ul 360 ul 7.2 ml 4 ml
_0CX (anhydrous 
2AM Mg5D4)
1 ml 1 ml 1 ml 20 ml
10CX Dextrose 1 ml 1 ml 20 ml 1C mil
0 5 to fina 1 vc lu me: 100 ml IOC im. 100 mL 2 L 1 L
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**Homogenization Buffer Recipe (keep on /ce)
P r e l i m i n a r y  B u f f e r V o l u m e 2 x V o l u m e
1% N P - 4 G  Lys i s  B u f f e r 9 5 8  ul 2 * 9 5 8  ul
P M S F 1 0  ul 2 0  ul
O r t h o v a n a d a t e 1 0  ul 2 0  ul
L e u p e p t i n 1 0  ul 2 0  ul
B - g l y c e r o l p h o s p h a t e 1 0  ul 2 0  ul
A p r o t i n i n l u l 2  ul
A n t i p a i n l u l 2  ul
aCSF Normoxia pH (7.4) solution
Compound FWt wt for 500ml of lOx Final 10X
aCSF concentration(M)
NaCI 58.44 35.05 g 1.20
NaHC03 84.01 19.20 g 0.4570
KCI 74.55 1.23 g  0.033
NaH2P04-H2O 138 830 mg 0.012
HEPES buffer aCSF_________________________________________________________
Compound FWt gfor500mL gfor2Lof5x Final working
_____________________________ of lOx HEPES HEPES_________ concentration(mM)
NaCI 58.44 35.06 70.12 120
NaHC03 84.01 8.40 16.8 20
HEPES acid 238.3 7.96 15.92 6.68
HEPES salt 260.3 4.29 8.58 3.30
KCI 74.55 1.86 3.72 5.00
Anhydrous 120.30 1.20 2.40 2.00
M g S C > 4
Other stock solutions used__________________________
Compound (Final concentration) Grams/volume
MgS04 anhydrous (2.4 M) 2.96g/100ml
CaCI2-2H20 (0.5 M) 7.35g/100ml
Glucose (1.0 M)__________________________ 18.02/lQQml
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